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ABSTRACT
Tissue engineering is an exciting technology that may provide replacement tissue and
organs for patients requiring transplantation therapy. Crucial to the preparation of
engineering soft tissues is the cellular scaffold which must resemble the cells native
environment and be mechanically robust. Hydrogel materials present the greatest
potential as candidate materials for soft tissue scaffolds, however, it is very
challenging to identify hydrogel materials that satisfy the extensive list of
performance criteria required for this application. This thesis describes several
hydrogel materials that are prepared from gellan gum and gelatin. The main focus of
this thesis is the mechanical characterisation of these materials which is aimed
towards addressing the performance criteria of soft tissue scaffold materials. The
materials’ degradability, swelling behaviour and gelation behaviour were also focal
points of this research.
It was found that genipin cross-linked gelatin hydrogels could be prepared to be
thermally stable, self-supporting and degradable, with pH sensitive swelling
behaviour that were compatible with endothelial cells. Commercial gellan gum was
able to be purified of inorganic contaminants, which improved its gel-forming
ability, but diminished its mechanical performance. Ionic-covalent entanglement
(ICE) hydrogels of gellan gum and gelatin possessed excellent mechanical strength
and a self-recovering ability when subjected to mechanical deformation. The ICE
hydrogels were successfully fabricated as microspheric particles, which were
subsequently demonstrated to be capable of mechanically reinforcing gelatin
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hydrogels. These materials may have significance for the field of tissue engineering
because of their mechanical potential to be used as soft tissue scaffold materials.
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1.1

Tissue engineering

Every day, people are in need of organ and tissue transplants. For many people an
organ transplant is their last resort and a lifesaving treatment. Transplantation
therapy was acknowledged in the 2008 Australian National Clinical Taskforce’s
report as the most effective treatment for end-stage renal failure and for those that
would otherwise die of heart, liver or lung failure1. Tissue transplantation is also
regarded as a highly effective treatment for those requiring new skin, cardiac and
musculoskeletal tissues1. As of 2008, it is estimated at any given time in Australia
there are approximately 1700 people waiting for an organ donation, approximately
50 of which are children1. Depending on the organ, these people could be expected to
wait between six months and four years before they receive a transplant, and some
might die before they receive one at all1. Generally, organs and tissue only become
available when someone donates them upon their death and as a consequence of this,
the supply of donated organs and tissue is vastly short of the demand for them.
In their seminal review, Robert Langer and Joseph Vacanti describe the emerging
field of tissue engineering as the application of “the principles of biology and
engineering to the development of functional substitutes for damaged tissue”2. It is
anticipated that tissue engineering technologies may one day provide a plentiful
supply of cost efficient and highly compatible laboratory grown tissue and organs for
implantation2. Tissue engineering may also provide the opportunity to enhance our
current physiology, and create spin-off technologies which could accelerate the
development of new drugs and our understanding of diseases3. Many tissue
engineering materials are comparatively cheap to obtain making them potentially
cost effective alternatives to donor transplantations4. Tissue engineering materials
4

and cells could also be hypothetically harvested and expanded from a patient biopsy
or blood sample would eliminate the problem of organ/tissue incompatibility and
greatly reduce the occurrence of immunological rejection which can occur in
conventional donor transplantation therapy5,6.
It is now widely accepted that all tissue engineering schemes must carefully consider
and integrate three critical components – i) cells, ii) a scaffold, and iii) cellular
stimulation (Figure 0-1)2. Cells, once harvested from the patient and expanded in
vitro, can be incorporated into a scaffold where they will grow, proliferate, and
remodel their environment until it is ready to assume its function in the body7,8. In
the past, acellular therapies have been attempted but it was revealed that by relying
solely on cellular intrusion from the surrounding tissue, maturation happens too
slowly or not at all2. Scaffolds are 3D architectures comprised of various components
that can include structural materials; biological materials like proteins, or growth
factors; and in some cases even functional materials like conductors9. The properties
of these scaffolds should resemble the extracellular matrix and they should also be
designed to initially hold cells in place and deliver bioactive molecules, whilst
maintaining space for tissue to develop10,11. The scaffold can also be designed and
fabricated in such a way as to guide cellular migration and blood vessel growth
which are very important12–14. Cellular stimuli, typically in the form of growth and
differentiation factors (but also may include electro/mechanical stimuli and matrix
stimuli), is also essential to tissue maturation15. Cells respond to stimuli by producing
enzymes, matrix materials, cytokines and by undergoing cellular processes such as
differentiation and proliferation16.
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Figure 0-1: Schematic of basic tissue engineering strategy. Cells are harvested from the patient in a
biopsy (a); which are then expanded in vitro (b); which can then be incorporated into a scaffold along
with cellular stimuli (c) to create an engineered tissue which can then be transplanted back into the
patient (d). Figure adapted from reference17.

Engineered tissue has already been successfully used as replacement tissue for the
treatment of damaged and diseased tissue as well as being used as in vitro models for
the study of various tissue pathologies. Tissue engineered skin has been successfully
used to treat patients with full thickness burns and skin diseases including vitiligo,
melanoma, psoriasis and blistering disorders (Figure 0-2a)18 as well as being used as
a model for the in vitro study of psoriasis19. Large size blood vessels have also
successfully been engineered and employed as adult vascular grafts for bypass
surgeries (Figure 0-2c)20,21. Other examples of successful engineered tissues which
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have emerged recently and are used for transplantation therapy and pathological
studies are heart valves (Figure 0-2c), bronchial tissue and cornea tissue22–24. These
tissue engineering successes demonstrate that the concept of tissue engineering in
plausible, however there are numerous challenges in the field which are still unmet.
Of the many challenges still faced, the oldest and most prevailing challenge has been
the development of good scaffolds for in vitro tissue engineering that meet the
extensive schedule of design criteria (for example biocompatibility and porosity).
Another challenge has been the preparation of larger and more complex tissues and
ultimately the engineering of entire organs which are ultimately too intricate and
delicate to be fabricated by hand or traditional casting and moulding technologies.
For these the most promising way forward here is computer aided fabrication using
rapid prototyping and additive manufacturing technologies such as extrusion
printing. Unfortunately, there are not many scaffold materials that are capable of
being printed effectively so there is a challenge to find scaffold materials that are
printable. Current successes in tissue engineering have been for relatively simple and
small or thin pieces of tissue because larger and thicker pieces are harder to nourish
properly. The incorporation of a vascular network within the scaffold to supply
nutrients and oxygen to the cells within is a major challenge preventing the
preparation of larger pieces of engineered tissue. Certain tissue types, such as
cartilage, require especially tough and resilient scaffold materials to become
achievable. Unfortunately, traditional hydrogel materials are weak and brittle, so the
development of tougher hydrogel materials is current challenge in soft tissue
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engineering. These challenges will now be discussed in further detail because they
provide the context for the materials presented in this thesis.

Figure 0-2: Examples of successfully engineered tissues: a) Tissue engineered skin (reproduced from
National Geographic website); b) a tissue engineering trileaflet heart valve23; c) an engineered
vascular graft21.

1.2

Materials for tissue scaffolds

The cellular scaffold is a critical component of in vitro tissue engineering strategies2.
It’s primary role is to maintain a space for the tissue to develop in and to hold the
cells in place25. For this to happen, the scaffold must allow cells to adhere to it;
possess the room required for growth and proliferation; and permit them to intrude
and occupy the material all the way through25. It may also incorporate a vascular
8

network for supplying nutrients and oxygen, and removing of metabolites and carbon
dioxide throughout the construct which will ultimately integrate with the patient
vasculature14,26,27. Additionally, it is advantageous to encourage cell growth,
proliferation, differentiation and function by way of topographic and biomolecular
cues (loading of growth and differentiation factors)28. The biological compatibility of
the scaffold and its constituent materials are also important: the materials must not be
immunogenic, cytotoxic, or in any way hinder cellular function29. Finally, most
scaffolds should be fully assimilated into the patient over time and therefore must
biodegrade as it is replaced by the cells own natural extracellular matrix30.
Scaffolds for tissue engineering can either be recycled from old or created from new
(de novo). Scaffold recycling refers to the use of a decellularised scaffold from
another organism which has some distinct advantages over de novo scaffolds as well
as some major drawbacks. The main advantages of decellularised scaffolds is that
they retain the complex micro- and macro-structure of the target tissue and are
constructed from native tissue so are therefore inherently biocompatible (excepting
where tissue from other organisms is used)31. However the scaffolds must first
undergo a decellularisation process as well as sterilisation to ensure there are no alien
cells or pathogens carried forward, and these processes can damage the delicate
scaffold features and leave immunogenic and cytotoxic residues32,33.
The alternative to scaffold recycling is to create a new one from scratch (de novo)
which offers the ultimate in versatility with regards to materials and design.
Hydrogels are the most appropriate materials for engineered soft tissue scaffolds
because, generally, they mimic and match the mechanical properties of natural soft
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tissues which is essential to avoiding shearing around the implant10,34,35. In addition
to mechanical properties there are many other special properties of hydrogels that
also make them suitable scaffold materials such as biological properties and
degradability. Hydrogels can be produced from many different types of polymers and
can be synthesised, blended, modified and processed to meet the necessary
performance criteria for any type of soft tissue scaffold.
Hydrogels are materials comprised mainly of water (up to ~99%) with the remainder
being a hydrophilic polymer network that confines the water within its boundaries36.
Hydrogels can be processed using relatively mild conditions and aqueous
chemistries. Over the past 30 years an extensive array of both naturally derived and
synthetic hydrogel-forming polymers have been utilised for various soft tissue
engineering objectives37. However, hydrogel-forming polymers need to be suited for
their specific application, and for tissue engineering, this means they must be
prepared from biocompatible polymers using either non-toxic reagents (or in the case
of toxic reagents, using those which can be completely removed after the scaffold
has been fabricated)10,38. It is also often required that hydrogel-forming polymers
possess gel-forming mechanisms which allow the encapsulation of cells during
processing; i.e. if cells must be integrated in the scaffold during fabrication, the gel
formation process must not harm the cells39,40. Furthermore, control of the
degradability of hydrogel-forming polymers is critical as the lifetime of the material
has to suit the tissue engineering application – specifically, temporary scaffolds need
to degrade but permanent implants must not41.
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1.2.1

Hydrogel-forming polymers

Hydrogel-forming polymers can be classified according to their synthetic origins,
composition, electrostatic nature and gel forming mechanism (Figure 0-3). These
same traits are critical considerations when selecting a hydrogel-forming polymer for
specific tissue engineering applications and the ability to utilise a particular
fabrication method.
Hydrogels are formed from either naturally produced polymers (also referred to as
biopolymers) or synthetic polymers. Biopolymers are derived from various
organisms including human, animals, plants and bacteria and are generally, more
compatible and more likely to interact positively with cells42. Human derived
biopolymers such as collagen and fibrin have the greatest biological compatibility
and possess proteolytic pathways of degradation (proteolysis by specific enzymes),
whilst those non-human derived biopolymers such as alginate or chitosan have less
compatibility

and

degradability43.

Notwithstanding,

many

human

derived

biopolymers are often preferentially derived from non-human sources because they
are more available and cheaper to produce. For example hyaluronan, which is a
glycosaminoglycan produced in humans, is much more efficiently produced from
bacteria44. Historically, plant derived biopolymers (e.g. alginate, agarose, cellulose)
have been used in cell culture and are inexpensive and easy to obtain, however,
because they are completely foreign molecules to humans they have at best
intermediate biocompatibility and no proteolytic degradation mechanism within the
body44. There are major drawbacks with biopolymers, including significant
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variations in molecular weight and structure from batch to batch and they may also
present a risk of pathogen transfer from the originating organism45.
Synthetic polymers usually possess superior mechanical properties and can be
produced in large quantities, consistently, cheaply, and above all, are easy to modify
to produce hydrogels with desirable properties. There is no risk of pathogens being
present in a synthetic polymer hydrogel however care must be taken to ensure that
there is no trace of toxic unpolymersied/uncross-linked reagents left in the hydrogel
prior to use46. Most synthetic polymers are not biocompatible; have limited
biodegradability; and have poor cellular adhesion, however, many of these
shortcomings have been addressed to some extent with clever processing and
modification strategies15,42,47.
A new class of synthetic hydrogel forming materials that are comprised of small
discrete (organic) molecules, such as peptides is worth mentioning in this space
although it will not be described in as much detail as biopolymers and synthetic
polymers. This new class of material show much promise in potential application to
tissue engineering scaffold materials and presents a new space to explore in hydrogel
science48. It is recommended that the intrigued reader be directed to the work of
Samuel Stupp for an excellent description of the subject48.
Polymers can also be classified based on their composition and, more specifically,
the monomers/types of monomers from which they are made. Most biopolymers
used for tissue engineering are either proteins/polypeptides, polysaccharides, or
glycosaminoglycans while the most prevalent synthetic hydrogel-forming polymers
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are polyols, polyethers or polyesters. Proteins and polypeptides are the most
functional of all biopolymers because they contain peptide domains that interact
directly with cells49 and perform specific functions (e.g., signalling and cellular
adhesion), and usually there are enzymes in the body that specialise in degradation of
these polymers7,50. Conversely, proteins are also relatively expensive to mass
produce and have limited lifetimes7,50. Polysaccharides are a diverse class of
biopolymers obtainable from many plant and microbial life forms which makes them
a very versatile and cost effective hydrogel materials42. Many polysaccharides are
also polyelectrolytes that can form ionotropic hydrogels or complex coacervate
hydrogels such as gellan gum51 and alginate44. Glycosaminoglycans are a class of
polysaccharides that contain amine functionality and deserve special mention
because they, in combination with various proteins, form the natural extracellular
matrix of human cells and consequently have excellent biocompatibility and cellular
affinity11,52. Polyols, polyethers and polyesters can be produced cheaply with
consistency but are generally less degradable than biopolymers, with the exception of
polyesters derived from naturally occurring α-hydroxy acids which possess greater
biocompatibility and are to some extent biodegradable or excretable53.
Another distinguishing feature of hydrogel-forming polymers is their electrical
nature which directly relates to how a hydrogel can be formed. The electrical nature
of a polymer is derived from the inherent functionality of the monomers it is
constructed from. Certain functional groups are ionisable in aqueous solutions; for
example the amino groups in gelatin are positively charged in acidic solution and the
carboxylate groups of alginate are negatively charged in alkali solution4,54.
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Polysaccharides are often anionic in nature due to an abundance of carboxylate or
sulfate containing moieties within their structure such as gellan gum which has one
carboxylate containing saccharide unit in every four55. There are also
polysaccharides that are cationic due to an abundance of amine containing monomer
units (e.g. chitosan)56. Glycosaminoglycans, by definition, contain amino groups in
their structure but also usually contain an excess of carboxylic acid functionality and
hence are almost exclusively anionic in nature (e.g. hyaluronan)57. Proteinaceous
biopolymers are comprised of a mixture of amino acids with many different negative
and positively charged functional groups. Proteinaceous polymers are amphoteric
polyelectrolytes because the population of positive and negative charges in protein
molecules is mediated by the pH of the solution and its isoelectric point (pI). By no
means are all biopolymers also polyelectrolytes, in fact, there are a number of
neutrally charged polysaccharides such as agarose, dextran and cellulose, however,
almost all polyols, polyethers and polyesters are neutral in nature58–61.

Figure 0-3: Hydrogel-forming polymers can be classified by origin (blue), composition (red) and
electrical nature (green). To some extent, the origin, composition and electrical nature are related
(arrows).
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1.2.2

Hydrogel formation mechanisms

The mechanism by which a hydrogel forms has a direct impact on the methods used
to fabricate the hydrogel component for tissue engineering. In general, certain gel
forming processes lend themselves to rapid prototyping fabrication methods while
others require more time to develop into robust hydrogels and are suited to slower
fabrication techniques such as porogen leaching62,63. All hydrogels possess some
level of physical attraction between macromers as a result of hydrogen bonding and
entanglements amongst one another40. Often these physical interactions are strong
enough to form a weak gel but these are seldom strong enough for tissue engineering
applications or layer upon layer fabrication. Usually a hydrogel intended for tissue
engineering applications must be strengthened through additional electrostatic
interactions or chemical cross-linking (Figure 0-4)64.
Ionotropic hydrogels are those formed as a result of electrostatic interactions between
polyanions and cations or polycations and anions. For example, alginate is a
polyanionic polymer comprised of mannuronic and glucaronic acid residues which
forms a firm ionotropic hydrogel upon addition of calcium ions65, and chitosan is a
polycationic polymer containing glucosamine residues, which are positively charged
above its isoelectric point and will form a firm ionotropic hydrogel with phosphate
ions66. Ionotropic hydrogels are usually able to form a firm hydrogel upon cooling
and are therefore particularly useful for in situ tissue engineering or for use in rapid
prototyping fabrication techniques (e.g. extrusion printing)65,67. Ionic cross-links are
also able to be repaired if broken which can be beneficial68. Hydrogels intended for
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use as cartilage tissue scaffolds comprised of gellan gum and epoxy amine polymers
have been demonstrated to recover after physical deformation69.
Complex coacervate hydrogels, also sometimes referred to as polyion complexes or
polyelectrolyte complexes, are formed upon mixing of a polyanion and a polycation
with one another such as alginate and poly(L-lysine) or sometimes also with an
amphoteric polymer such as chondroitin sulfate and gelatin40,70.
Almost all hydrogels are also able to be directly cross-linked with various chemical
cross-linkers, or at least be pre-functionalised so that they can be subsequently crosslinked71. The variety of cross-linking methods and reagents are large and many crosslinking reagents are toxic and must be fully removed from the hydrogel before they
come into contact with cells or a body66. It is also possible to incorporate
proteolytically degradable sequences using covalent cross-linking chemistries to
improve the degradability of otherwise non-degradable polymers72, such as the
inclusion of proteolytically degradable sequences into Poly(ethylene glycol)
hydrogels demonstrated by Baldwin and Kiick and Patterson and Hubbel (Figure
0-5a)42,72.
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Figure 0-4: Schematic of different hydrogel-forming mechanisms: Chemical cross-linking, ionotropic
cross-linking, and complex coacervate formation.

1.2.3

Degradation behaviour and biocompatibility

It is often advantageous for a hydrogel-forming polymer to be degradable via a
natural process whose degradation rate matches the rate of the production of new
extracellular matrix37 (but in some cases a non-permanent implant is desirable)12.
Hydrogel-forming polymers are generally degraded by either proteolysis or by
hydrolysis73. Proteolysis occurs when an enzyme that is produced by the cells in or
around the implant are able to recognize a degradable peptide sequence in the
polymer which it can sever7,72. Collagen for example, is a proteinaceous biopolymer
which can be degraded through the action of matrix metalloproteases called
collagenases74. The main advantage of proteolytically degradable polymers are that
17

they will be degraded at a rate that more closely matches that of cellular growth
because the cells are programmed to produce these enzymes to make room for
themselves to grow into52. Many hydrogel polymers are also able to be hydrolysed
without the aid of an enzyme under physiological conditions but at a significantly
slower rate75 which can be advantageous if a longer lasting implant is desired.
Synthetic polyesters of α-hydroxy acids are the only synthetic polymers that can be
degraded in a natural way into their naturally occurring monomers and subsequently
consumed in the tricarboxylic acid cycle76. Poly(lactic acid) and poly(glycolic acid)
are examples of α-hydroxy acid based polymers which have been used extensively in
biomedical engineering as degradable stents, sutures and wound dressings77–79. Most
other synthetic polymers used in tissue engineering are generally non-degradable and
are often either selected for use in applications that require more persistent materials
or limited to low molecular weight analogues (< 5,000 Da) which are able to be
removed via the renal system53,80,81. Alternatively, non-degradable hydrogel-forming
polymers may have degradable regions built into their structure to impart finely
controlled degradability72. Poly(ethylene glycol) is a prevalent example of a synthetic
polymer with poor inherent degradability which can and has been modified to
include enzyme-cleavable domains and improve its degradability25,47,82.
Materials for use in tissue engineering must be compatible with the body of the
intended patient. Further, the interaction between cells and biomaterials as well as
biomaterials and the body needs to be carefully considered when selecting hydrogelforming polymers for tissue engineering applications. The term biocompatibility is
often used to describe this concept, which is an ambiguous term which has evolved
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and changed meaning in line with the evolution of our understanding of the
interaction between biomaterials and the body83. In this thesis, a biocompatible
material is defined as one which does not incite a foreign body reaction on its own; is
non-inflammatory or otherwise immunogenic; and is non-cytotoxic. The foreign
body response is a reaction to the inclusion of a foreign material such as a tissue
engineered construct which can be detrimental to the function of the implant84. Often
a hydrogel scaffold on its own can be responsible for a foreign body reaction, but
cells and other inclusions in an implant may also contribute84. Certain hydrogelforming polymers have been observed to stimulate particularly strong foreign body
reactions such as carrageenan which is frequently used to test the efficacy of antiinflammatory reagents in animal models85,86.
The ability of cells to adhere to the scaffold is also an important aspect of hydrogelforming polymers to consider. The adhesion of cells to their hydrogel scaffold has
been demonstrated to provide important stimulation to the cells and directs their
differentiation and activity87,88. Lack of cellular adhesion can also result in anoikis
(apoptosis induced by inadequate cell-matrix interactions)89. Cells can adhere to a
scaffold through specific “lock and key” type interactions such as the integrin and
heparin binding domains in cells and extracellular matrix proteins90. Many hydrogelforming polymers do not inherently possess specific cellular adhesion regions but
instead may be modified to do so by immobilising proteins onto the polymer91. By
far the most prevalent strategy to improvement of cellular adhesion is the tethering of
the integrin binding RGD domain to the polymer backbone (Figure 0-5b)45,92–95. The
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non-adherent polysaccharide gellan gum has been demonstrated to have significantly
improved cellular adhesion when the RGD peptide sequence has been tethered to it96.

Figure 0-5: a) A schematic representation of star-PEG modified with MMP-cleavable domains and
heparin which was used to prepare a degradable synthetic hydrogel that releases pro-angiogenic
vascular endothelial growth factor (VEGF)97. b) A confocal micrograph of a selectively RGDSmodified star-PEG hydrogel (green colour) with fibroblasts adhered and guided in this region (pink
and blue)95.

Table 0-1 presents the most prevalent hydrogel-forming polymers used in tissue
engineering with a summation of their most pertinent characteristics to their utility as
cellular scaffolds (polymer class, functionality, degradability, biological response,
activity and compatibility, and gel formation mechanism). These polymers include
familiar polymers which have been used in biomedical devices, formulations and in
cell culture protocols for decades such as gelatin and collagen, and also include more
recently investigated materials like carrageenans and gellan gum. From the schedule
of hydrogel-forming polymers presented in Table 0-1, gellan gum and gelatin were
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selected as the main materials to be used throughout the research presented in this
thesis. The polymers will now be described in greater detail in the following sections.
1.2.4

Gelatin and genipin

Gelatin is a proteinaceous biopolymer produced from the controlled hydrolysis of
collagen, which is the primary constituent of the extracellular matrix in all
connective tissues in the human body54. Commercially, gelatin is produced from
collagen by either alkali or acid hydrolysis, however, gelatin with a variety of
isoelectric points have also been produced from the enzymatic degradation of
collagen98. The source of the collagen and the method of production affect the
molecular weight distribution, isoelectric point, colour, transparency and related
properties54. “Type A” gelatin is prepared from acid treated porcine skin collagen
and is the most frequently used gelatin in biomedical applications on account of its
gelation properties, low cost and optically transparency98.
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Table 0-1: Description of polymers used in tissue engineering categorised by class; biological response, activity and biocompatibility; degradability; and hydrogel-forming
mechanism.
Polymer

Agarose

Alginate

κ-Carrageenan

Chitosan

Chondroitin Sulfate

Collagen

Dextran

Elastin

Fibrin

Gelatin

Description and functionality
Polymer comprised of Dgalactose and 3,6-anhydro-Lgalactose with ether
functionality
Polyelectrolyte comprised of Dmannuronic acid and Lguluronic acid with carboxylate
and hydroxyl functionality
Polyelectrolyte comprised of Dgalactose and 3,6-anhydro-Dgalactose with hydroxyl and
sulfate functionality
Polyelectrolyte comprised of Dglucosamine and N-acetyl-Dglucosamine with amine and
hydroxyl functionality
Polyelectrolyte comprised of Nacetyl-D-galactosamine and Dglucuronic acid with amide,
carboxylate, hydroxyl and
sulfate functionality
Polyelectrolyte comprised of
various amino acids with amine,
carboxylate and hydroxyl
functionality
Polymer comprised of DGlucopyranose with hydroxyl
functionality
Polyelectrolyte comprised of
various amino acids with amine
and carboxylate functionality
Polyelectrolyte comprised of
various amino acids with amine,
carboxylate and hydroxyl
functionality
Polyelectrolyte comprised of
various amino acids with amine,

Class

Biological response, activity and
compatibility

Degradability

Hydrogel-forming mechanism

Neutral,
polysaccharide
biopolymer

Not biocompatible4,99

Non degradable100

Physical gel formation below 36˚C58

Anionic,
polysaccharide
biopolymer

Varying biocompatibility, high Lguluronic acid content alginates are
more immunogenic44

Hydrolysis4
Ion exchange/chelation4

Ionotropic gel formation with divalent
cations4

Anionic
polysaccharide
biopolymer

Inflammation inducing86, but also
demonstrated anti-tumoral44

Hydrolysis101

Ionotropic gel formation with
monovalent cations44,102

Cationic,
polysaccharide
biopolymer

Biocompatible, non-cytotoxic, antibacterial, anti-fungal, anti-tumoral56,103

Hydrolysis103
Proteolysis (lysozyme)103

Chemical gel formation via crosslinking of amino groups4,104

Anionic
glycosaminoglycan
biopolymer

Biocompatible4

Proteolysis (chondroitinase)105

Complex coacervate gel formation with
cationic polyelectrolytes42

Amphoteric,
proteinaceous
biopolymer

Biocompatible, non-toxic, with good
cellular adhesion but potentially
immunogenic106

Proteolysis (collagenase)74

Physical self-assembling gel formation
and chemical gel formation via crosslinking of amino or carboxylate
groups107

Neutral,
polysaccharide
biopolymer
Amphoteric,
proteinaceous
biopolymer

Biocompatible but has poor protein and
cellular adhesion60, and is potentially
immunogenic108

Hydrolysis109

Ionotropic gel formation in the presence
of K+ 59,60

Biocompatible, but is hydrophobic and
insoluble88,110

Proteolysis (elastase)111

Covalent (self-assembling)110

Amphoteric,
proteinaceous
biopolymer

Biocompatible with excellent protein
and cellular adhesion77, thrombogenic112

Proteolysis100

Covalent (self-assembling)113

Amphoteric,
proteinaceous

Biocompatible108 with good cellular
adhesion114

Proteolysis (collagenase)115

Physical gel formation below 27˚C and
chemical gel formation via cross-
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Gellan gum

Hyaluronan

Methylcellulose

Poly(acrylamide)

Poly(caprolactone)
Poly(ethylene glycol)
Poly(glycolic acid)
Poly(glycerol sebacate)
Poly(2-hydroxyethyl
methacrylate)
Poly(lactic acid)
Poly(propylene
fumarate)

Poly(vinyl alcohol)

carboxylate and hydroxyl
functionality
Polyelectrolyte comprised of Dglucose, D-glucuronic acid and
L-rhamnose with carboxylate
and hydroxyl functionality
Polyelectrolyte comprised of
glucuronic acid and N-acetyl-Dglucosamine with amide,
carboxylate and hydroxyl
functionality
Polymer comprised of D-glucose
with hydroxyl functionality
Polymer comprised of
acrylamide with amide
functionality
Polymer comprised of εcaprolactone with ether
functionality
Polymer comprised of ethylene
oxide with ether functionality
Polymer comprised of glycolic
acid with ester functionality
Polymer comprised of glycerol
and sebacic acid with ester and
hydroxyl functionality
Polymer comprise of 2hydroxyethyl methacrylate with
ester and hydroxyl functionality
Polymer comprised of lactic acid
with ester functionality
Polymer comprised of propylene
fumarate with ester functionality
with ester and vinyl
functionality
Polymer comprised of vinyl
alcohol with hydroxyl
functionality

biopolymer

linking of amino or carboxylate
groups116,117

Anionic,
polysaccharide
biopolymer

Biocompatible118, non-cytotoxic119, but
has poor cellular adhesion96

Hydrolysis55
Ion-exchange/chelation55

Ionotropic gel formation with cations120

Anionic,
glycosaminoglycan
biopolymer

Biocompatible121, with good cellular
adhesion57

Proteolysis (hyaluronidase)122

Ionotropic formation with cations123

Neutral,
polysaccharide
biopolymer

Biocompatible61

Non degradable61

Physical gel formation at a temperature
dependant on the degree of
methylation61

Neutral, synthetic
polymer

Non-toxic polymer, but monomer is
neurotoxic124

Non degradable124

Covalent125

Neutral, synthetic
polyester

Biocompatible126

Hydrolysis127

Covalent127

Neutral, synthetic
polyether
Neutral, synthetic
polyester

Biocompatible47, but with poor protein
and cellular adsorption47
Intermediate biocompatibility, mildly
immunogenic128

Non degradable47

Covalent47

Hydrolysis129

Covalent129

Neutral, synthetic
polyester

Biocompatible, non-cytotoxic130,131

Hydrolysis131

Covalent131

Neutral, synthetic
polymer

Intermediate biocompatibility, mildly
immunogenic132

Non degradable133

Covalent81

Neutral, synthetic
polyester

Intermediate biocompatibility, mildly
immunogenic134

Hydrolysis135

Covalent135

Neutral, synthetic
polyester

Inflammation causing material136

Hydrolysis136

Covalent137

Neutral, synthetic
polyol

Biocompatible, but with poor protein
and cellular adhesion138

Non degradable139

Covalent138,139

23

Gelatin shares many of collagens inherent properties, including complete
biocompatibility,

non-toxicity,

non-carcinogenicity and

biodegradability via

collagenase proteolysis39,140,141. However, there are some distinct advantages for
gelatin in comparison to collagen. The denatured structure resulting from the
conversion of collagen to gelatin significantly decrease its antigenicity and reduces
the risk of transferral of pathogenic species from the original animal142. Gelatin is
also generally cheaper than collagen, and materials produced from gelatin are less
prone to batch-to-batch variation143. Another important distinguishing feature is
gelatin’s superior solubility – collagen self assembles into insoluble fibrils but gelatin
doesn’t, which makes gelatin easier to process and modify using solution based
chemistries143.
Gelatin has been used prolifically in the pharmaceuticals industry, primarily as a soft
or hard capsule to encapsulate drugs144. It has also been used in surgical applications
such as wound dressings, surgical sponges, sealants and glues145–148. Gelatin has also
been historically used as a coating on cell culture plates for the culture of endothelial
cells, muscle cells and embryonic stem cells149. Furthermore, gelatin has been
studied for use as a scaffold for tissue engineering applications, in particular as a
component in bone composite materials141,150,151, articular cartilage152,153, as guiding
conduits for nerve regeneration154–156 and as a non-thrombogenic material for
vascular tissue engineering157.
Ordinarily, gelatin based materials swell extensively, rapidly dissolve and degrade at
elevated temperatures (above the gel transition point ~29°C), and lose their strength
and rigidity rapidly54,158,159. Cross-linking of gelatin based materials is an effective
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method to address these disadvantages and even allows for the tuning of the material
properties and the opportunity to impart additional functionality160,161. Non-chemical
based cross-linking methods include dehydrothermal, freeze-thaw cycling, ultraviolet
irradiation and gamma irradiation115. Commonly used chemical cross-linking
reagents include gluteraldehyde, diisocyanates, polyepoxy compounds, acyl azides,
carbodiimides and genipin71,162. Gluteraldehyde cross-linking is by far the most
frequently utilised cross-linker but the toxicity of gluteraldehyde makes it
troublesome to use in tissue engineering applications. In fact the toxicity of most
chemical cross-linkers, and/or severity of the cross-linking reaction conditions,
prohibits their use in many tissue engineering applications.
Genipin (Figure 0-6) is the algycone of geniposide, an iridoid glycoside that is the
major component of the fruit of the gardenia plant, Gardenia jasmindides Ellis163. It
has recently emerged as a popular cross-linker for proteinaceous biopolymers such as
gelatin because it is equally effective as other popular cross-linkers but is also noncytotoxic, non-genotoxic and an anti-inflammatory agent46,164–166 which are virtuous
properties for a component of a tissue engineered scaffold material.

Figure 0-6: Structural diagram of genipin.
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Genipin forms chemical cross-links between the primary amino groups of either the
ε-amino groups of lysine and hydroxylysine residues, or the guanidinium group of
arginine residues in gelatin167. With respect to gelatin, it has been reported that 8590% of the free epsilon amino groups can be cross-linked with genipin162. The crosslinking mechanism is a two-step process (Figure 0-7)168. In the first step the ε-amino
group of lysine (or hydroxylysine) from gelatin is incorporated into the dihydropyran
ring resulting in formation of a tertiary amine link and loss of 2H2O. In the second
step, another ε-amino group from a different lysine residue replaces the methyl ester
group forming an amide bond to the genipin molecule and producing CH3OH.

Figure 0-7: Cross-linking mechanism for genipin and gelatin (R = an ε-amino group of gelatin).

One of the most distinct properties of genipin cross-linked polymers is the
development of a deep blue colour. This occurs because genipin, after reacting with a
primary amine group creates intermediate species that are able to undergo radical
polymerization with other genipin molecules initiated by oxygen radicals in the air.
The

intermediate

species

and

oligomers

of

genipin

can

then

undergo

dehydrogenation to produce conjugated systems that absorb photons of around 575
nm wavelength, producing the strong blue colour168–170. These blue pigments are
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commonly known as the edible blue food dye “gardenia blue”. Fortunately, the
polymerisation of the genipin and the formation of the intermediates do not inhibit
the ability to cross-link gelatin163,169.
Genipin cross-linked gelatins have been used for various biomedical applications
over the last 10 years. In 2003, a study of genipin cross-linked gelatin wound
dressings were compared with gluteraldehyde cross-linked wound dressings where it
was demonstrated that both were effective as wound dressings, but the healing rate
for the genipin cross-linked dressing was significantly faster and inflammatory
reaction significantly lower than the gluteraldehyde cross-linked counterpart147.
Microspheres prepared from genipin cross-linked gelatin have also been used as
intramuscular drug delivery vessels where it was shown that inflammatory response
was minimal, and that swelling, drug retention and release and degradation could be
controlled by the degree of cross-linking171. Genipin cross-linked gelatin materials
have also been explored as a component of nerve-guiding conduits for peripheral
nerve gap regeneration in rat models154–156; a component of bone composites for
bone tissue scaffolds141,150; and as a scaffold material for articular cartilage tissue
engineering152,153. Finally, genipin cross-linked gelatin microspheres have been used
as cellular micro-carriers of hepatocytes which were used in the regeneration of liver
tissue172–174.
1.2.5

Gellan gum

Gellan gum is a polysaccharide biopolymer produced from the bacteria
Pseudomonas elodea and is commercially marketed under the trade names GelriteTM
and KelcogelTM

175,176

. The molecular structure is a repeating tetra saccharide unit
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consisting of: one α-L-rhamnose, one β-D-glucuronic acid and two β-D-glucose
residues (Figure 0-8 a-b)175,176. Native gellan gum (high acyl gellan gum or HAGG)
has one acetyl substituent bound to every tetramer. The degree of acylation can be
decreased (hereafter referred to as low acyl gellan gum or LAGG) with alkali
treatment and is often performed to modify the gel properties177,178. HAGG forms
opaque, soft and more flexible hydrogels, whilst LAGG forms transparent, hard and
more brittle hydrogels (Figure 0-8c)178–180. For example, 2% (w/v) HAGG with 5
mM Ca2+ possesses a compressive modulus of 87 ± 3 kPa and compressive failure
stress of 50 ± 8 kPa, compared to 2% (w/v) LAGG with 5 mM Ca2+ which has a
compressive modulus of 540 ± 20 kPa and a compressive failure stress of 130 ± 5
kPa180.

Figure 0-8: The structural diagrams of a) high acyl gellan gum and b) low acyl gellan gum177; c) a
photograph of typical gellan gum hydrogels prepared with low acyl gellan gum, high acyl gellan gum
and a 1:1 blend180.
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Gellan gum solutions form hydrogels upon cooling to below the sol-gel transition
temperature which lies between 30°C and 50°C51. Upon cooling, random coils of
gellan gum molecules change to a double helix conformation which aggregate
together to form weak hydrogels in the absence of cations (Figure 0-9)119,181. The
presence of cations in the gel solution affects the gelation of gellan gum because they
are able to interact with charged carboxylate groups on the polymer backbone. When
monovalent cations are present, the cations are able to shield opposing negatively
charged carboxylate groups so that the double helical aggregates can form firmer
junction zones and create stronger hydrogels (Figure 0-9)182. When divalent cations
are present, even stronger gels are formed because the divalent cation acts as a crosslink between carboxylate groups to form even stronger junction zones (Figure 0-9).
Gellan gum hydrogels which have been cross-linked with divalent cations will not
return to the solution state upon reheating to above the sol-gel transition
temperature178.

Figure 0-9: Schematic representation of conformation of gellan gum in its random coiled state, weak
gel state and strong gel state through temperature changes. Adapted from reference120.
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Calcium cross-linked gellan gum is an attractive material for tissue engineering
because of its inherent gelation properties and its resemblance to native
glycosaminoglycan ECM materials. The cross-linking mechanism for gellan gum is
particularly amenable to certain tissue engineering techniques such as in
situ/injectable cellular therapies183,184. Calcium ion cross-linking in particular
produces very firm hydrogels and is a comparatively non-toxic cross-linking
alternative to many other chemical cross-linkers55. The hydrogels are also degradable
via ion exchange process where calcium ions are swapped for sodium ions180. Gellan
gum is also one of the few polysaccharides that are commercially available in
endotoxin free form and approved for use in pharmaceuticals by the FDA177.
However, gellan gum has also been known to produce a mild inflammatory response
in vivo184.
Gellan gum has been used in various biomedical applications and as an agar
alternative for plant cell culture120. Gellan gum has also been intensively researched
as a controlled release/drug delivered vehicle183,185,186. It has been used in ophthalmic
therapeutics to retain, localize and slowly release eye medicines (the gellan gum
solution gels upon contact with tear fluid and stops the medicine from running
straight out of the eye)187. It has also be used as an in situ gelling solution for oral
drug delivery, where a gellan solution containing the drug of interest gels
spontaneously in the highly acidic stomach environment and subsequently releases
the drug slowly over time183. As far as tissue engineering applications are concerned,
gellan gum has been used mostly as a scaffold for the engineering of articular
cartilage tissue119,184 and intervertebral discs188. Bolus injection of gellan with human
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chondrocytes has been demonstrated as a potential in situ tissue engineering strategy
toward cartilage regeneration184. Recently, gellan gum has also been used to prepare
cellular inks for use in bio-plotter technology for tissue engineering96.
1.3

Large and complex tissue engineering

Most successfully engineered tissue to date has been on relatively simple, small
and/or thin tissue pieces such as skin. However, ultimately it would be desirable to
create all tissue types and even whole organs. Several ideas and technologies have
evolved which are crucial steps towards achieving whole organ tissue engineering
objectives. One paradigm shift that has worked towards this end is the transition
from attempting to engineer new tissue inside the body (in vivo), to engineering
tissue outside of the body (in vitro)189. Two other technologies which have also
contributed greatly and will continue to contribute whole organ engineering are the
implementation of computer aided tissue engineering and additive fabrication
technologies such as extrusion printing. These concepts have a direct and indirect
relationship to the materials that are compatible with them and hence will now be
discussed in further detail.
1.3.1

In vivo and in vitro tissue engineering

The conventional in vivo tissue engineering strategy involves an injection of cells
within a polymer matrix at the site of tissue damage/loss and is sometimes simply
referred to as “cellular therapy”190. The polymer matrix acts as a scaffold and creates
a space which fills cavities in the damaged tissue, providing an environment for new
cell and tissue growth to occur191. A benefit of this strategy is that the injection is a
minimally invasive surgery which greatly reduces the potential for post-operative
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infection192. Unfortunately this treatment is not appropriate for large or complex
tissue repairs.
A very different but noteworthy in vivo tissue engineering strategy makes use of an
arteriovascular loop (AV loop) to culture new tissue193. It is possible to surgically
implant a scaffold within an AV loop so that the component will be invaded by fine
blood vessels over time to enable nutrients to be supplied directly from the blood
stream194. The scaffold can be slightly more complex compared to other in vivo
scaffolds and will naturally grow a vasculature over time, however the maximum
size of the component that can be grown is limited by the size of the AV loop
chamber, and it will of course require two additional surgeries – explantation and reimplantation195.
Alternatively, engineered tissue can be designed and constructed outside of the body
(in vitro). Cells from a patient biopsy can be expanded in vitro to a useable quantity
in 2D or 3D cell culture techniques139. The scaffold can be carefully designed and
fabricated so as to have complex shapes and internal structures conducive to tissue
development196. Cells and cellular stimuli can be spatially distributed throughout the
scaffold during fabrication197. In short, the in vitro tissue engineering strategies offers
an overall more versatile and scalable method for creating replacement tissue and
organs198,199. The in vitro engineered scaffolds are hypothetically ready for use from
the moment of implantation and can be tailored to the patient whilst in the laboratory.
Adopting the in vitro strategy is the most logical step towards the creation of larger
and more complex types of tissue and is surely essential for the fabrication of entire
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new organs. More than ever before, the scaffold is of critical importance to the in
vitro approach as support structures for the tissue would be completely absent
otherwise.
1.3.2

Computer aided tissue engineering

The ultimate destination of the tissue engineering field is the fabrication of whole
organs, however the structure and composition of organs is extremely complex and
would be practically impossible without the assistance of computers and additive
manufacturing technologies. Computer aided tissue engineering (CATE) is a concept
that builds upon the idea of in vitro tissue engineering and may one day facilitate the
concept of whole organ printing200,201. CATE, as the name suggests, utilises
computer aided technologies to improve upon classical laboratory methods, it
incorporates 3D medical imaging to measure and diagnose defective tissue/organs;
3D computer modelling and computer aided design software to prepare the blueprint
for the replacement tissue/organ to be created; and additive manufacturing equipment
such as 3D extrusion printers to precisely control the spatial placement of cells,
scaffold material and cellular stimuli (an example of this approach is depicted in
Figure 0-10).
Through use of the CATE methods, complex tissue and hopefully whole organs
could one day be produced which are tailored specifically to individual patient needs
in an “on-demand” fashion202,203. The hypothetical scenario would go something like
this: A patient with damaged kidneys would have the organ scanned to determine the
shape and size required for a replacement; computer modelling software would be
used to design the blue print for a healthy kidney based on the scans; and then the
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healthy kidney would be manufactured, potentially all in the hospital on the day of
diagnosis200.

Figure 0-10: An example of a human tooth being engineering using CATE technology 201. A 3D model
was prepared from micro-computer tomography scans and used as the blueprint for the fabrication of
a tooth shaped scaffold using projection-based micro-stereolithography201.

1.3.3

Extrusion printing of hydrogel scaffolds

Extrusion printing is a technique based on building structures by driving material out
of a nozzle and onto a stage. The extruded material is either directed by moving the
nozzle above the stage or by moving the stage underneath the nozzle; irrespectively,
3D structures are created through continuously depositing material layer-upon-layer.
In order to successfully build 3D structures in this manner, the first layer needs have
structural integrity before the second layer is deposited. Consequently, parameters
such as polymer rheology and the gel forming mechanism are critically important;
polymer solutions must be either viscous or viscoelastic initially, and then become
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self-supporting gels before additional layers are deposited. Temporal control of
gelation is crucial to avoid premature gelation of the polymer solution while it is still
in the printer. To this end, several strategies for printing hydrogel-forming polymers
are presented below.
Polymers which form hydrogels mainly through physical associations tend to possess
a gel transition temperature below which the solution gels, such as agarose,
methylcellulose, gelatin and collagen. Hot solutions of these polymers can be printed
onto a cooled stage whereupon the polymer traverses its gel transition temperature
and solidifies. Agarose is an example of a polymer which has been printed in this
manner where the polymer solution was held in the printer reservoir at 60°C-80°C
and printed into a cool bath below the gel transition temperature (Figure 0-11a)204,205.
A limitation of this approach is that physical hydrogels tend to be very weak and may
need to be reinforced using other polymers or with a post-print cross-linking step. A
compromise must also be made with respect to the magnitude of the temperature
drop; if the temperature drop is small, the polymer solution will have a high viscosity
and require high pressure to expel, but if the temperature drop is large it will take a
long time to cool down and gel. In some instances the initial and final temperature of
the polymer solution/gel may also exclude it from being able to include cells during
printing.
Photo-curable hydrogel-forming polymers can be printed onto an illuminated stage
where they will form firm hydrogels upon the incidence of light206. Some polymers
can be directly photo-cured if the appropriate photoinitiator is incorporated. For
example, it has been demonstrated that any proteinaceous biopolymer which contains
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tyrosine residues (such as collagen, fibrin and gelatin) can be cross-linked with white
light in the presence of Ru(II)bpy32+ photoinitiator (Figure 0-11b)207–209. Even
polymers with are not ordinarily photo-curable (such as gellan gum or dextran) may
be modified to become photo-curable, often through a straightforward reaction with
an acrylate or methacrylate based agent210,211. Photo-curable polymer printing has
been reported using PEG-acrylate and PPO-acrylate functionalized polymers without
cells, as well as with solutions of gelatin-methacrylate and hyaluronan-methacrylate
functionalized polymers mixed with cells206,212–214. The main advantage of photocurable polymer printing is that this type of polymerization is usually very rapid (a
few seconds to a few minutes) and is generally cell-friendly210.Also, because the
reactive stimulus is light in this case, so a bath is not needed and the time scale of
gelation can be adjusted by changing the intensity of the light.
Reactive printing of ionotropic polymers is a very successful method used to date for
extrusion printing of scaffolds. It involves printing a polymer solution into a bath of
reactive substance that induces gelation. Usually, this is performed with ionotropic
hydrogels and a bath containing a solution of the appropriate counter-ion204,215. It has
been reported in several instances that alginate has been printed into a calcium
solution in this manner to produce microspheres as well as more complex
structures196,216,217(Figure 0-11c). The main advantage of reactive printing of
ionotropic polymers is the very rapid gelation (approximately 1 second). The
polymer solution and the bath can be held at cell culture temperature (37 °C) and the
gel forming method itself is cell-friendly. In fact, it is possible to print gellan gum
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solutions with cell culture media whereupon a gel is formed instantly (Figure 0-11d)
197

.

Figure 0-11: Examples of computer aided tissue engineering constructs made from hydrogels. A) a
porous cube of agarose hydrogel printed using a thermal modulation approach; B) a porous mesh disc
shaped scaffold printed from photo-curable gelatin-methacrylamide; C) an aortic valve conduit printed
with a blend of alginate/gelatin hydrogel196 and differently scaled aortic valves printed from PEG-DA
hydrogels (scale bar is 1 cm)218; D) a cellular ink of gellan gum and mouse myoblasts is printed in
spirals on a glass microscopy slide (scale bar is 500 µm)197.

Although the pathway to the construction of engineered whole organs using
computer aided approaches is obvious, the materials which are both tissue
engineering and extrusion printing compatible are scarce. What is direly needed in
this field are materials which meet the performance criteria of tissue engineering as
well as being capable of being used in additive manufacturing, i.e., are capable of
being reactive printed and gelling rapidly into firm gels.
1.4

Vascularisable tissue scaffolds

Arguably one of the greatest challenges faced in the field of tissue engineering today
is mass transfer limitations in thick tissue components which limit the supply of
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nutrients and oxygen to cells – the so called “thick tissue dilemma”3,219. In natural
human tissue, blood vessels act as service conduits and it has been observed that cells
situated more than a couple hundred micrometres from a capillary blood vessel suffer
from hypoxia and apoptosis because nutrients, waste, oxygen and carbon dioxide are
unable to diffuse through more than several hundred micrometers of tissue/scaffold26.
As a consequence, the size of a non-vascularised tissue engineered component is
limited to less than ~ 500 µm thicknesses or restricted to the few tissues types that do
not require a vasculature such as heart valves, cartilage and bone.
People have sought to address the thick tissue dilemma using a variety of different
approaches219. Possibly the simplest strategy has been to increase the porosity and
pore interconnectivity of tissue scaffolds so that oxygen and nutrients can diffuse a
greater distance through the scaffold220. However, this approach can mechanically
weaken the scaffold and there is still a definite limit of diffusion, albeit an extended
one220. Researchers have also sought to circumvent the problem altogether by
choosing cells that are resistant to low oxygen conditions, but these cell types are too
constrictive for some engineered tissues3. Some success has been made by
accelerating the growth of vasculature in a scaffold by loading it with pro-angiogenic
factors and/or cell types which stimulate the production of vasculature221. This
approach is limited somewhat by the slow growth rate of blood vessels (~5 μm.hour1

) which must intrude into the scaffolds222. Excessive loading of pro-angiogenic

factors may also lead to the formation of tumours and other angiogenesis-related
pathologies223. A promising approach is pre-vascularisation of the scaffold before it
is implanted into the patient9,14,224,225.
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Generally speaking, blood vessels are formed either de novo by a process called
vasculogenesis, or by angiogenesis where new vessels sprout from existing
ones226,227. In vasculogenesis, mesodermal cells first cluster and arrange themselves
to form the basic framework of blood vessels228,229. They then differentiate into
angioblasts and hemangioblasts, followed by further differentiation into endothelial
cells and mural cells230. Angiogenesis begins when endothelial cells are stimulated
by vascular endothelial growth factor (VEGF) to proliferate and produce matrix
metalloproteases (MMP)

231

. The MMP disrupt the basement membrane and

extracellular matrix (ECM) to allow for endothelial cells to intrude into surrounding
tissue and form tubular structures231. Finally, mural cells are recruited from the
surrounding tissue and other blood vessels to form a new basement membrane and
stabilise the nascent capillaries231.
With the in vitro tissue engineering approach, it is possible to develop a vasculature
within the construct before it is implanted (in fact, it is the ability to do this that is a
distinct advantage of in vitro strategies versus in vivo strategies). It is possible to
completely guide the growth of the vasculature with topographical and chemical cues
created during scaffold fabrication which provides an extra element of control over
the design of the scaffold95. It is also possible to use the vasculature of a prevascularised scaffold to nourish the bulk of the tissue during culture in a perfusion
bioreactor232.
Once a pre-vascularised tissue component is implanted it is not immediately
integrated with the host vasculature so blood does not flow through the component
straight away and apoptosis may subsequently occur233. However, it has recently
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been demonstrated that vascular inosculation can be stimulated to form functional
junctions between scaffold and host vasculatures (Figure 0-12)222. Vascular
inosculation is a process that involves the host microvasculature extending blood
vessels into the scaffold where they abut other blood vessels belonging to the
scaffold vasculature234. The vascular intrusion can be initiated and invigorated by
pro-angiogenic growth factors222. Once blood vessels are touching they can knit
together if the basement membrane of the vessels are destabilised which can be
achieved through the action of certain angiopoeitins222,235.

Figure 0-12: Schematic representation of a) vascularisation of an un-vascularised scaffold by the
process of infiltration, and b) vascular inosculation of a pre-vascularised tissue scaffold236. c) a typical
mouse dorsal skinfold model for studying of vascularisation and d) a close up view of a prevascularised scaffold in the same model that has been inosculated over several days 222.
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Often, after successful connection of the blood supply, the vascular network of the
scaffold will undergo remodelling which involves the regression of unnecessary
blood vessels and creation of new blood vessels222. The vascular tree is pruned where
hyperoxic regions of tissue exist causing non-perfused blood vessels to regress, and
extend into the anoxic regions of tissue where hypoxic endothelial cells up-regulate
production of VEGF which in turn stimulates angiogenesis237.
1.5

Tough tissue scaffolds

For some tissue engineering objectives (such as cartilage tissue scaffolds), tougher
and more robust hydrogels which have the capacity to recover from mechanical
deformation are required. Conventional hydrogels have poor mechanical properties
because there are very few energy dissipation mechanisms to impede crack initiation
and crack propagation. When under stress, forces cannot be evenly distributed over
every polymer chain equally as the distance between the cross-linking points varies.
When the shortest polymer chain fractures, all the load is immediately transferred to
the next shortest chain which may subsequently break, and so on238. Hydrogels can
be made substantially tougher using a variety of modern hydrogel science strategies
including topological hydrogels239, tetra-PEG hydrogels240, double network (DN)
hydrogels241–244, ionic covalent entanglement (ICE) network hydrogels68,69,245,246, and
microgel reinforced (MR) hydrogels247. Figure 0-13 puts the mechanical
performance of these various hydrogel types into perspective.
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Figure 0-13: Charts depicting the different types of materials and hydrogels and their tensile
mechanical properties a) work of extension and modulus, b) tensile strength and elongation at
break238.
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The DN approach has been proven to be one of the most successful approaches to
preparation of tough hydrogels and has been explored extensively by J. P. Gong and
co-workers

using

poly(2-acrylamido,2-methyl,1-propanesulfonic

acid)

and

poly(acrylamide) (PAMPS/PAAm) systems242. Here, gels are prepared in a two-step
scheme where a PAMPS hydrogel network is swollen in acrylamide (monomer)
which is subsequently photo cross-linked (Figure 0-14 a-c)241,242,248. They have
determined that “the rigid and brittle PAMPS network serves as a sacrificial bond
that fractures at a relatively low stress, while the soft, ductile PAAm network serves
as hidden length that sustains stress by large extension afterwards” (Figure 0-14 de)242. Gong’s original DN hydrogels possessed an unprecedentedly high compressive
fracture stress of 17.2 MPa, but as they indicate, the hydrogels are permanently
deformed by the breaking of covalent bonds and do not recover like many tough
biological materials241. Gong has also hypothesised that “the introduction of any
sacrificial bonds that yield and dissipate energy upon deformation will toughen the
materials”249 and that “the same DN gel concepts can, in principle, be applied to
other self-healing types of materials, if the covalent bonds are replaced by reversible
bonds”242. This hypothesis has been tested and found to be true by Gong and others
by preparing gels with different types reversible sacrificial bonds including the
hydrophobic interactions of molecules forming lamellar bilayers250 and ionic crosslinks between ionotropic polymers68,69,245.
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Figure 0-14: a-c) Schematic representation of the formation of a double network hydrogel, where a
highly cross-linked polyelectrolyte network (blue) is swollen in a solution of monomer (black dots)
which is subsequently polymerised (c). Also depicted are schematic representations of the topological
changes incurred in DN hydrogels during tensile strain (d) and a tearing fracture (e). Figure adapted
from reference238,242.
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The incorporation of ionic sacrificial bonds into an interpenetrating network (IPN) of
two polymers has led to a class of tough and self-healing hydrogels referred to as
ionic-covalent entanglement (ICE) network hydrogels68,69,245. ICE network hydrogels
comprise a polyelectrolyte which is ionically cross-linked and a neutral polymer
which is covalently cross-linked (Figure 0-15a)69. Under stress, the sacrificial ionic
cross-links are easily dissociated and when the stress is removed the ionic cross-links
are able to reform and restore integrity to the hydrogel (Figure 0-15b). The ICE
network gels reported so far have demonstrated enhanced strength and toughness
compared to conventional hydrogels of the same polymers68,69,245,246. The extra
virtues of ICE network hydrogels compared to other tough hydrogels cannot be
understated: i) ICE network hydrogels can recover their original structure after
deformation, they are “self-healing”, ii) ICE network hydrogels are prepared in onestep syntheses and form firm gels upon cooling245. This means that they can be
printed or moulded into complex shapes, or even be formed in situ – properties
which are particularly attractive for the field of tissue engineering.
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Figure 0-15: Schematic diagram of an ionic-covalent entanglement hydrogel showing the different
cross-linking junctions and polymer networks. a) Networks without crack initiated, b) networks with
crack initiated. Figure adapted from reference68.

Hydrogels can also be made stronger and tougher by reinforcing them with fibres,
plates and spheres much like conventional polymers can be. According to
conventional theory of polymer reinforcement, successful reinforcing particles are
ones which are stiffer and stronger than the matrix polymer; and have effective
coupling to between the reinforcer and the matrix251. Tough hydrogels have been
prepared using nanocomposite reinforcing (NC gels) in the form of exfoliated clay
platelets (~30 nm diameter) which act as multifunctional cross-linkers (Figure
0-16a)252. These hydrogels possessed excellent mechanical performance (tensile
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strength of 109 kPa; tensile modulus of 9.9 kPa and elongation at failure of 857%
when possessing a swelling ratio of 48)252. Microgels have also been used as
multifunctional cross-linker reinforcing to improve the mechanical properties of
hydrogels and are commonly referred to as microgel reinforced hydrogels (MRhydrogels) (Figure 0-16b)249,253–256. MR-hydrogels exhibit improved mechanical
properties because they too act as multi-functional cross-linking nodes that inhibit
the formation of micro-cracks and voids in the hydrogel254. Recently several double
network hydrogel microspheres were reported to improve the mechanical properties
of poly(acrylamide) hydrogels247,249,253.

47

Figure 0-16: a) Formation of NC hydrogels, b) formation of MR-hydrogels. Both methods are similar
in that the particles become a multi-functional cross-linking node. Figure adapted from reference238.
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The overall aim of this thesis was to explore the preparation of novel hydrogel
materials and to characterise them with respect to their mechanical properties,
swelling behaviour and degradability. In performing their research and developing
these materials, it was intended that these materials might reveal the potential to be
used as soft tissue engineering scaffolds so as to further advance the field of tissue
engineering. For this reason, some tissue engineering specific properties were also
investigated where appropriate such as the compatibility of the material with
endothelial cells and exploration of gelation properties which might be amenable to
extrusion printing in conjunction with cells.
Aim 1. Develop a gelatin based material that is thermally stable at 37°C,
degradable, has stable swelling properties, is mechanically robust and is
compatible with endothelial cells so that it might be vascularisable.
Aim 2. Develop a method for purification of LAGG and determine its resulting
properties in terms of gel-transition temperature and mechanical
performance so as to improve upon the original gelation properties of
commercial LAGG.
Aim 3. Develop an ICE hydrogel material from gellan gum and gelatin that is
stronger than conventional hydrogels and possess a self-recovering ability.
Aim 4. Explore the fabrication of ICE hydrogel microspheres and determine their
ability to mechanically reinforce gelatin hydrogels.
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1.6
1.6.1

Chapter summaries
Gelapin, a degradable genipin cross-linked gelatin hydrogel

Chapter 2 describes the preparation and characterisation of a hydrogel material
prepared from gelatin which was cross-linked with genipin and could potentially be
used as a vascularisable tissue engineering scaffold. The material was explored
through compressive mechanical analysis, rheometric analysis, analysis of its
swelling, leeching and degradation behaviour in a simulated physiological
environment and its ability to be vascularised using a chick chorioallantoic
membrane (CAM) assay. The concentration of gelatin and genipin used to prepare
hydrogels was shown to affect the mechanical performance, swelling, leeching and
degradation. Hydrogels prepared with 6% (w/v) gelatin and 20.3% (w/w) genipin
were able to be vascularised in a chick CAM assay when loaded with pro-angiogenic
substance phorbol-12-myristate-13-acetate.
1.6.2

Purification of gellan gum

Chapter 3 describes a method that can be used to purify commercial gellan gum from
divalent cation contaminants and presents the properties of the purified gellan gum.
Commercial gellan gum was shown to possess inorganic contaminants in the form of
sodium, potassium, calcium and magnesium which increased the temperature and
time needed to dissolve and hydrate the polymer and increased the temperature at
which the polymer solutions gelled. The purification method described in this
chapter could be used to prepare exclusively the sodium salt of gellan gum with 67%
yield which had desirable hydration and gelation temperatures with some deleterious
impact on mechanical performance.
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1.6.3

Biopolymer based tough and self-recovering ionic-covalent entanglement
hydrogels

Chapter 4 describes the development and characterisation of a hybrid hydrogel
material which was substantially stronger than most conventional hydrogels as well
as possessed the ability to recover its mechanical properties after compression. It was
found that the combination of genipin cross-linked gelatin and calcium cross-linked
gellan gum can be adjusted so that an ionic-covalent entanglement network hydrogel
was formed which had significantly higher mechanical performance than either
constituent polymer. Ionic cross-link sites in the gellan gum portion of the ICE
network could be reconstructed after deformation which imparted recover-ability to
the hydrogel. The gellan gum to gelatin ratio and genipin and calcium concentrations
were observed to affect the mechanical performance with distinct optima occurring
when the composition was 36% (w/w) gellan gum to 64% (w/w) gelatin, 2% (w/w)
calcium and 20% (w/w) genipin. The toughest hydrogels prepared possessed 1.0 ±
0.2 MPa compressive failure stress, Young’s modulus of 890 ± 50 kPa, work of
extension value of 126 ± 6 kJ.m-3 and could recover to 88% of their original work
under compression when rested for as little as 10 minutes in simulated body fluid.
The swelling and leaching behaviour of the hydrogels were also examined when
immersed in simulated body fluid as well as the mechanical performance of fully
swollen hydrogels.
1.6.4

Hydrogel microspheres

Chapter 5 describes the fabrication of hydrogel microspheres using emulsion based
processing. It shows how hydrogel microspheres can be prepared using oil and water
51

emulsions and focuses on parameters including type of oil, type of surfactant and
concentration of surfactant used to prepare the emulsions. The ability of the
microspheres to mechanically reinforce a hydrogel was also demonstrated.
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Abstract
The synthesis of genipin cross-linked gelatin (Gelapin) hydrogel materials is
presented. Gelapin hydrogels were comprehensively characterised through chemical,
mechanical and physical analysis techniques. It was found that the hydrogels could
be cross-linked to up to 90% using a genipin concentration of 24.4% (w/w). The
hydrogels reach a stable swollen state and cease leaching of residual starting
materials after 72 hours in phosphate buffered saline solution at 37°C. The
proteolytic degradation of Gelapin by collagenase is tuneable through manipulation
of the material composition with the rate of degradation ranging from 60 mg/day up
to 500 mg/day. The mechanical characteristics (at 37°C) are controllable through
adjustment of the gelatin and genipin concentrations resulting in compressive stressat-failure values ranging from 26 kPa to 300 kPa. Gelapin gels were found to become
more elastic and ductile during proteolytic degradation up to 70% mass loss. The
ability for vascularisation of these hydrogels was demonstrated using a chick embryo
chorioallantoic membrane assay method.
2.1

Introduction

The engineering of tissue and organs in a laboratory is a comparatively cost effective
and convenient alternative to human tissue and organ donations. The tissue scaffold,
i.e. the material that reinforces the component’s structure, and holds the cells in place
during maturation, is a critical component of all in vitro tissue engineering
strategies2. For engineering of soft tissues, hydrogel materials are the most
appropriate scaffold materials because they have similar mechanical properties and
chemical composition to natural tissues37,139.
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Hydrogels are a class of hydrated polymer materials whose polymer fraction
generally lies between 0.1 – 10 % (w/v), with the remainder comprising water or an
aqueous solution40. Typical examples of commercial hydrogel products include
toothpaste, foods, contact lenses, cosmetics, drug capsules and medical creams and
ointments. Over the past 30 years an extensive array of both naturally derived and
synthetic hydrogels have been utilised in research and development for all manner of
tissue engineering objectives37.
The study and use of gelatin hydrogels dates back centuries with the first
documented use of gelatin materials for biomedical application as a haemostatic
substance257. Since then it has been also been utilised for surgical glues, sealants and
wound dressings145,147,148,257. Gelatin is denatured, hydrolysed collagen which itself is
the primary constituent of all the connective tissues of the human body (within skin,
muscle, bones, cartilage, fat)54,158. It is produced commercially via acid and alkaline
hydrolysis and by proteolysis of collagen which can be derived from all manner of
organisms including, but not limited to: pigs, cows, fish and rats54,158. Depending on
the type and extent of hydrolysis/proteolysis and the originating species, different
gelatins can be produced with a variety of isoelectric points, molecular weights and
Bloom numbers (indicative of gel strength)258. Gelatin hydrogels have the advantage
of being biocompatible, non-toxic, non-immunogenic and biodegradable as well as
being cheap and readily available259, making them an ideal candidate materials for
biomedical applications162. However, unmodified gelatin hydrogels are mechanically
weak and dissolve at temperatures above 29˚C which are limitations that need to be
addressed in order to develop them for practical applications54.
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It has been demonstrated that the mechanical and thermal properties of gelatin
hydrogels can be improved by cross-linking116,160. Examples of reagents and methods
used for cross-linking gelatin include chemical cross-linking with gluteraldehyde,
formaldehyde, diisocyanates, carbodiimides and acyl azides260, as well as physical
cross-linking using dehydrothermal treatment, ultraviolet irradiation and gamma
irradiation162. However, the physical treatments tend to achieve a very limited extent
of cross-linking, and the chemical treatments have the potential to leave toxic
residues in the gels which will release upon biodegradation in vivo162. Novel crosslinking reagents that are both effective and non-toxic are required to improve the
mechanical and thermal properties of gelatin whilst retaining its inherent
advantageous properties.
Genipin is a potent yet non-toxic cross-linker of proteins such as chitosan, collagen
and gelatin that has been recently demonstrated to bestow anti-inflammatory
properties to the materials it is incorporated into162,164,165,168. It is produced both
synthetically and naturally as the algycone of geniposide, an iridoid glycoside that is
the major component of the fruit of the gardenia plant, Gardenia jasmindides Ellis46.
Genipin was first proposed and demonstrated for use as a biological tissue fixative
and gluteraldehyde alternative in 1999 where it was demonstrated to be 10,000 times
less toxic and almost equally efficacious46. It has been established that genipin crosslinked gelatin via the epsilon amino group present in lysine and hydroxylysine
residues (Supplementary Figure 2-1)167. Genipin has been used in the preparation of
cross-linked gelatin films and hydrogels161,162,261,262, and employed in nerve guiding
conduits, wound dressings, and cartilage scaffolds147,153,156.
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There is considerable interest in bioreactors for tissue engineering that can culture
three-dimensional constructs in a dynamic fashion, and can also perfuse scaffold
materials and stimulate their contents mechanically232,263–268. In particular,
mechanical stimulation has been shown to be crucial in directing the differentiation
and phenotype of many cell types towards phenotypes which can produce functional
extracellular matrix which will ultimately replace the scaffold and form the bulk of
the new tissue component266,267,269–273. In consideration of this aspect of tissue
engineering, it is obviously of benefit to have a thorough understanding of the
mechanical and rheological properties of candidate materials.
In this paper, the preparation and characterisation of genipin cross-linked gelatin
(Gelapin) is presented. The ability of genipin to act as a gelatin cross-linker was
investigated, including the stability and retention of both gelatin and genipin in
phosphate buffer saline solution at 37°C. The degradation behaviour and mechanical
characteristics of these hydrogels at 37°C are discussed in detail and their ability for
vascularisation is demonstrated.
2.2
2.2.1

Materials and methods
Preparation of hydrogels

All reagents used were AR grade unless otherwise stated and deionised (DI) water
(resistivity 18.2 MΩ cm) was prepared using a combined ion exchange and osmosis
filtration system (Millipore, Australia). Gelapin hydrogels were prepared with type
A, porcine gelatin (Bloom number of 300, molecular weight of 87,500 Da, SigmaAldrich, USA) with concentrations of gelatin ranging 2% - 10% (w/v) and genipin
(Challenge Bioproducts, Taiwan) concentrations ranging 0 – 19.5% (w/w).
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Throughout this report Gelapin hydrogels will be referred to using nomenclature that
describes their composition in the format Gelapin-[gelatin %(w/v)]/[genipin
%(w/w)]. A summary of the preparation regime is as follows: Gelatin was initially
dissolved with gentle stirring in DI water at 50˚C on a magnetic stirrer/hot plate
(Stuart CB162, UK). Subsequently, the appropriate amount of 20.3% (w/v) genipin
in 60% (v/v) ethanol (Ajax Finechem, Australia) solution was added and stirred for a
further 3 minutes at 50˚C. The hot solution was then poured into glass Petri dishes
(60 mm diameter x 15 mm height, Schott, Australia) and allowed to cure for 24 hours
at 21˚C. Silanisation of the Petri dishes with Coatasil (Thermofisher Scientific,
Australia) prior to use facilitated the easy removal of the hydrogels without
damaging them.
2.2.2
The

Extent of cross-linking
extent

of

cross-linking

in

Gelapin

hydrogels

was

determined

by

spectrophotometric comparison of the number of epsilon amino groups present in
cross-linked and uncross-linked gelatin. The method used was based on the
colorimetric assay developed by Offner and Bubnis274,275: Gelapin samples were first
lyophilised (LD Plus, Alpha, USA) and divided into 10 – 20 mg subsamples for
individual analysis. Each subsample was combined with 4 mL of 4% (w/v) NaHCO3
(Merck, Australia), 1 mL of 0.5% (w/v) 2,4,6-trinitrobenzenesulfonic acid (SigmaAldrich, USA) and heated in an oven (Binder-FD, USA) for four hours at 40˚C. The
subsamples were then acidified with 3 mL of 6 M HCl (Ajax Finechem, Australia)
and hydrolysed in an autoclave (Tomy ES-315, 121˚C, 186 kPa, 20 min). Three
extractions using 20 mL diethyl ether (BDH, Belgium) were performed after addition
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of 5 mL of DI water. A 5 mL aliquot of the aqueous extract was taken, heated on a
steam bath for 15 minutes and allowed to cool to 20˚C for 18 hours. The samples
were then made up to 20 mL and measured using a dual beam spectrophotometer
(Cary 500 Scan, Varian, Australia) in 1 cm path length glass cuvettes at 346 nm.
The extent of cross-linking (EC) was determined by comparing the cross-linked
blank corrected sample absorbance (A) to the non-cross-linked blank corrected
sample absorbance (Ao):

. (1)

2.2.3

Swelling behaviour

Gelapin hydrogels were placed into round plastic containers (60 mm diameter x 40
mm, Chanrol, Australia), filled with 40 mL of phosphate buffered saline (PBS)
solution (pH = 7.4, 3 mM NaN3) and stored in a controlled temperature/humidity
chamber (TRH-150-SD, Thermoline, Australia) at (37 ± 1)˚C for up to 168 hours.
The samples were removed from PBS solutions, padded dry with filter paper, and
weighed after 3, 6, 12, 24, 48, 72 and 168 hours. The PBS solutions were replaced
with fresh PBS solutions at 24, 48 and 72 hours. The swelling ratio (SW) was
calculated:

,

(2)

where Wi and Wt are the initial mass and the mass at different swelling times,
respectively.
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2.2.4

Genipin and gelatin leaching

Gelapin hydrogels were immersed in 40 mL PBS solution and stored in sealed round
container (60 mm diameter x 40 mm, Chanrol, Australia) at 40˚C for up to 72 hours.
At 24, 48 and 72 hours, the absorbance of the PBS solution (A24h, A48h and A72h,
respectively) was measured at 589 nm in the spectrophotometer in 1 cm glass
cuvettes. After each 24 hour period, the hydrogels were re-immersed in fresh PBS
solution. Although the specific quantity of genipin could not be determined in this
way, the amount of genipin released relative to the total leachable genipin (GR) was
calculated as:

,

(3)

where At is the absorbance measured at either 24, 48 or 72 hours.
At 24, 48 and 72 hours, the gelatin concentration in the same PBS solution was
measured using a Coomassie Blue protein assay kit (Coomassie Plus, Thermofisher
Scientific, Australia) in 96 well microplate format using a plate reader (Polarstar,
BMG Labtech, Germany) with an absorption spectrophotometer (595 nm). The
gelatin concentration was calculated from interpolation of the linear regression of a
standard curve. Calibration standards were prepared at gelatin concentrations of 0,
75, 150, 300, 450, 750, 1125 and 1500 μg/mL in duplicate and samples were
prepared in quadruplicate with separate blanks.

60

2.2.5

Proteolytic and hydrolytic degradation

Gelapin hydrogels were preconditioned by soaking in PBS solution in the
temperature/humidity chamber at (37 ± 1)˚C for 14 days.
Hydrogel samples were placed into tissue cassettes (model M512, Simport, Canada)
before being immersed in either collagenase solution for the proteolytic degradation
study, or PBS for the hydrolytic degradation study. The collagenase solution was
prepared from a lyophilized mixture of collagenases isolated from Chlostridium
histolyticum (Sigma, USA) in PBS to a concentration of 10 2-furanacryloyl-Lleucylglycyl-L-prolyl-L-alanine (FALGPA) units/mL. One unit of FALGPA
hydrolyses 1.0 mmol of FALGPA per min at 25 °C and pH 7.5 in the presence of
calcium ions. The samples and solutions were kept at (37 ± 1)˚C for the duration of
the study and had the collagenase and PBS solutions changed regularly.
For each mass measurement, the samples in their cassettes were removed from the
collagenase/PBS solution, dried and then weighted. The drying procedure involved
drip-draining the majority of the solution from the cassettes, followed by blotting and
wicking the solution away with tissue paper. The mass of the samples (ms) were
calculated by subtracting the mass of the cassettes (mc) from the mass of the samples
in their cassettes (mt):
.

(4)

The extent of degradation (D) was calculated every 24 hours as:

,

(5)
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where mt is the mass of the sample at a particular point in time and mi is the initial
mass. The degradation rate and the induction period were determined from the slope
and the intercept of the steady-state region in a plot of the extent of degradation
versus time.
2.2.6

Rheological properties

The rheological properties of Gelapin hydrogels were examined using a rheometer
(Physica MCR-301, Anton Paar, Australia) with Peltier temperature controlled
bottom platen and 15.0 mm parallel plate measuring system. All measurements were
conducted at (37.0 ± 0.1)˚C with 15.0 mm diameter samples; a gap length of (1.00 ±
0.01) mm and (1.0 ± 0.1) N of normal force. The following experiments were
conducted sequentially (with at least one minute rest between experiments): Strainsweep experiment, where the oscillating frequency was held constant at 1 Hz and the
oscillating strain was varied from 0.01% up to 10%; a frequency-sweep experiment,
where the oscillating strain was held constant at 0.05% and the oscillating frequency
was varied from 0.8 Hz –80 Hz; a creep recovery experiment, where samples were
subjected to a non-oscillating shear stress of 10 Pa for a period of 5 seconds and then
allowed to relax. The linear viscoelastic (LVE) region was defined in these
experiments as the strain for which the storage modulus deviates by more than 5% of
the initial (low strain) value.
2.2.7

Compressive mechanical properties

The mechanical properties of the full compositional range of Gelapin hydrogels was
assessed using a universal mechanical analyser (EZ-S, Shimadzu, Japan). Prior to
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analysis,

the

hydrogels

were

immersed

in

PBS

solution

within

the

temperature/humidity chamber (37 ± 1)˚C for 72 hours. The instrument was adapted
to incorporate a heated bath of PBS solution held at (37 ± 2)˚C, so that samples were
immersed during analysis. These compression tests were performed at a strain rate of
3 mm/min with samples that had been cut with a scalpel to rectangular prism
geometry of ~ 10 mm x 10 mm x 8 mm. Stress-strain data was used to determine the
compressive failure strain (εmax), compressive tangent modulus over 20%-30% strain
(Etan), compressive failure stress (σmax) and compressive strain energy to failure (U).
The mechanical properties of Gelapin hydrogels with composition of 4% (w/v)
gelatin and 9.7% (w/w) genipin were assessed during degradation via collagenase
proteolysis. Prior to testing, hydrogels (20 mm diameter, 5 mm height) were allowed
to equilibrate in PBS solution followed by immersion in the collagenase solution.
Partially degraded samples were removed at regular intervals during the proteolytic
degradation process and subjected to compressive mechanical testing.
2.2.8

Angiogenesis

To examine the ability of blood vessels to intrude into Gelapin hydrogels and form
nascent blood vessels the chick chorioallantoic membrane (CAM) on-plant assay was
conducted which utilises the highly vascularised CAM as an experimental model of
angiogenesis in situ276. Grey rooster/white hen cross-bred fertile chicken eggs (Barter
and Sons Hatchery, Australia) were incubated (HERAcell, Kendro Laboratory
Products, Germany) for three days at 38˚C and 60% relative humidity before
separation of the shell from the embryo, yolk and albumin. The embryo was then
incubated (37.8˚C, 5% CO2) for a further three days before Gelapin on-plants were
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laid upon the surface of the vitelline. The embryos were then returned to incubate for
a further four days, during which evidence of angiogenesis was monitored via optical
microscopy (Z16, Leica, Germany).
Gelapin-6/9.7 on-plants were prepared in the absence (control) and presence of 0.5
μM phorbol-12-myristate-13-acetate (PMA) as a chemical stimulator of angiogenesis
(Cayman Chemical, USA)277. Partially cured gels were then dispensed into the cavity
of the on-plant device consisting of the space between two 5 mm squares of sterile
mesh (Nylon-6,6, 180 μm grid size, 47% open area, Sefar Pty Ltd, Australia) and a
spacer (Nylon-6,6, internal diameter 5.3 mm, external diameter 11.0 mm, 1.0 mm
thickness, RS Components Pty Ltd, Australia). The gels were then allowed to cure
and solidify over 4 more hours before being immersed in PBS solution and rested for
an additional 18 hours to allow uncross-linked genipin to leach out and for the gel to
shrink to its equilibrium size.
Macroscopic images were taken with a digital camera (Lumix DMC-FT1, Panasonic,
Japan). Microscopic images were taken with the microscope with attached digital
camera (DFC-290, Leica, Germany). Image analysis was performed with the Leica
Application Suite (Leica, Germany). Assessment of the extent of angiogenesis, both
in and around the on-plants were made on the basis of the number of blood vessels
intersecting the on-plant boundary at 60˚-120˚ in a spherical area with radius 10 mm
from the centre of the on-plant. Other qualitative assessments were also made by
inspecting above and below the on-plants and measuring the range and thickness of
the surrounding blood vessels.
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2.2.9

Statistical treatment of data

Dixon’s Q-test (95% confidence) was used to confirm and justify the removal of
spurious data. Unless otherwise stated, the data presented in this manuscript are the
mean ± one standard deviation (SD).
2.3
2.3.1

Results and discussion
Extent of cross-linking

Hydrogels were prepared by cross-linking gelatin with genipin. The extent of crosslinking (EC) is a measure of the effectiveness of genipin as the cross-linker for
gelatin and was used to determine the amount of genipin required to obtain specific
amounts of cross-linking in all subsequent experiments. The EC ratio presents the
percentage of cross-linking sites in gelatin that form part of a cross-link versus the
total amount of potential cross-linking sites and is calculated as described in
Equation 1. The ratio was found to increase with increasing genipin concentration
(Figure 2-1). The maximum extent of cross-linking attainable for Gelapin hydrogels
was observed to be 84% – 90% for all concentrations of gelatin examined. This data
can be used to predict the concentration of genipin required to attain any EC desired
or vice-versa.
Our results are in agreement with those of Bigi and co-workers162, who suggested
that genipin is unable to attain 100% EC due to a shielding effect of the gelation
tertiary structure, which prevents some of the lysine residues from reacting with
genipin. Smaller and more flexible cross-linking molecules, such as gluteraldehyde
have been reported to attain a maximum EC of 100%260. Notwithstanding, genipin
should still be considered an effective cross-linker of gelatin, especially when one
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considers that it has been demonstrated that genipin is not cytotoxic46,166 and bestows
anti-inflammatory character164,165.

Figure 2-1: Extent of cross-linking in Gelapin hydrogels as a function of genipin concentration.
Diamonds, squares and triangles represent gelatin concentrations of 2%, 5% and 10% (w/v),
respectively.

2.3.2

Swelling behaviour

The swelling ratio of Gelapin hydrogels was observed to be dependent on both the
gelatin concentration and the cross-linker concentration (Supplementary Table 2-1).
The swelling profiles of all hydrogels could be described as an initial rapid decrease
in size which slowed to a steady state where no further significant change in mass
occurred (an example profile for the Gelapin-10/X hydrogels is presented in Figure
2-2). The hydrogels all exuded water to varying extents, dependant on their
composition (Supplementary Table 2-1). For 2%, 3% and 4% (w/v) gelatin hydrogels
it took 48 hours of soaking before the equilibrium swelling state was reached. For
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5% and 10% (w/v) gelatin hydrogels, it took 72 hours to reach the equilibrium
swelling state. The extent of de-swelling was found to be inversely proportional to
the gelatin concentration and directly proportional to the genipin concentration. This
behaviour is consistent with the Flory-Rehner theory where hydrogel volume is
affected by the balance between osmotic pressure and elastic restorative forces278.
Hydrogels which contain more gelatin possess a greater osmotic pressure which acts
to draw water into the gels and increases the equilibrium volume, while those with
more extensive cross-linking possess a greater elastic restorative force which
decreases the volume at equilibrium.
Some Gelapin hydrogels were not physically stable in simulated physiological
conditions, PBS solution at 37 °C and pH 7.4. Hydrogels compositions comprising of
2% (w/v) gelatin and less than 7.3% (w/w) genipin; 3% (w/v) gelatin and less that
4.9% (w/w) genipin; and 4% (w/v) gelatin with 2.4% (w/w) genipin, dissolved
completely over 24 hours of soaking. These hydrogels possess relatively low
concentrations of gelatin and genipin and therefore possess only a small amount of
polymer entanglement and covalent cross-links. It is suggested that this causes them
to dissolve when the temperature of the hydrogels is raised from the curing
temperature (~20˚C) to the temperature (37˚C) at which all testing is carried out.
It is well known that proteinaceous hydrogels, such as Gelapin are particularly
sensitive to changes in pH which affect the balance of charges on the polymeric
backbone278. This was demonstrated by investigating the swelling behaviour in PBS
soaking solutions (at 37°C) of pH 8.2. Under these conditions it was observed that
the SW was higher compared to the corresponding gels swollen in PBS at pH 7.4.
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Figure 2-2: Swelling ratio as a function of time for typical Gelapin hydrogels with gelatin
concentration of 10% (w/v). Diamonds, squares, triangles and crosses indicate genipin concentrations
of 4.9, 7.3, 12.2 and 19.5% (w/w), respectively.

2.3.3

Genipin and gelatin leaching

Gelapin hydrogels were immersed in PBS solution at 37 °C and pH 7.4 for several
days during which the leaching of genipin and gelatin were monitored regularly. A
noticeable amount of genipin in the form of partially reacted (not cross-linked) blue
genipin pigments was observed to leach from the Gelapin hydrogels during 72 hours
of immersion in PBS solution. The blue pigments are commonly known as the edible
blue food dye “Gardenia Blue” and are a result of interactions between genipin and
gelatin168. The percentage of genipin released (GR) was calculated according to
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Equation 3 at 24 h, 48 h and 72 h (data not shown). It was observed that the majority
(>89%) of the genipin was released during the first 24 hours for all of the Gelapin
hydrogels.
Insignificant amounts of gelatin were released from Gelapin hydrogels whilst being
immersed in PBS (Supplementary Table 2-2). The majority of the gelatin was
released within the first 24 hours of soaking with no detectable amount being
released on subsequent days. The amount released was inversely proportionate to the
extent of cross-linking. This is likely to be a result of cross-links tethering gelatin
molecules together as well as contributing to confinement and entanglement of noncovalently cross-linked gelatin molecules. This initial release may represent the
superficial, unbound gelatin. These results demonstrate that by increasing the amount
of cross-linking, the gelatin release can be slowed or extinguished altogether.
2.3.4

Proteolytic and hydrolytic degradation

The extent of proteolytic and hydrolytic degradation (D) of Gelapin hydrogels were
obtained using mass measurements of samples immersed in PBS solution with and
without collagenase, respectively, over 93 days. Samples of hydrogel which had been
immersed with collagenase were observed to lose mass at three different rates
(Figure 2-3a, Table 2-1), referred to as the initial, steady state and tailing periods. In
the initial (induction) period the infiltration of the hydrogel by collagenase
commences and it begins to make scissions in the gelatin. During this period the
hydrogel was being degraded but there was no significant change in mass loss until
there were enough scissions made in the matrix to dislodge fragments from the bulk
material. For samples immersed in collagenase, the induction period was found to be
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proportionate to the amount of cross-linking in the Gelapin hydrogels, i.e. it was
instantaneous for the least cross-linked hydrogels and up to 2 days for the hydrogels
with the highest degree of crosslinking.
In the second (steady state) period, the degradation rate for the hydrogels immersed
in collagenase solution ranged from 60 mg/day up to 500 mg/day and was observed
to be dependent on both the gelatin concentration and the concentration of the
genipin (Figure 2-3b). Increasing the gelatin concentration increased the density of
the hydrogel producing a less penetrable matrix for collagenase and partially
degraded matrix to diffuse through. As a result, the degradation rate observed for
high gelatin content hydrogels was lower than that of the low gelatin content
hydrogels. Gels with higher concentrations of the genipin cross-linker exhibited
slower degradation rates. It is suggested that the covalent cross-links formed with
genipin molecules are resistant to degradation by collagenase and may be tying
partially degraded gelatin molecules together and contributing to their entanglement
for longer periods of time than less densely cross-linked Gelapin hydrogels.
In the third (tailing) period, of the degradation rate decreased until the entire material
was degraded. During this period, degradation is limited by the available surface area
of the sample which diminishes in proportion to the radius of the sample squared.
Consequently, as the sample is degraded to a smaller size, the sample area and
degradation rate decrease quickly. The total time it took samples to degrade via
proteolysis ranged from 3.5 ± 0.5 to 49 ± 3 days and was proportionate to the gelatin
and genipin concentrations (Figure 2-3c). Slower degradation rates were observed for
higher gelatin content and more extensively cross-linked Gelapin hydrogels which
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had a direct effect on the overall time taken to degrade the component. In contrast,
Gelapin hydrogel which were not exposed to collagenase did not show significant
signs of degradation over 93 days, or a time period which is twice as long as it took
for the most robust Gelapin hydrogels to degrade completely in collagenase. In fact,
most samples increased in mass by a small amount which may be a result of swelling
(Table 2-1). This suggests that in the absence of matrix metalloproteases such as
collagenase, Gelapin hydrogels will not significantly degrade as a result of
indiscriminate hydrolysis.
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Table 2-1: The inductions times (tI), degradation rates (D) and degradation times (tD) for proteolytic
degradation and the hydrolytic mass change (ΔM) for Gelapin hydrogels after a 93 day hydrolytic
degradation period. The nomenclature of Gelapin hydrogels describes their composition in the format
Gelapin-[gelatin %(w/v)]/[genipin %(w/w)].

Sample

Proteolytic
tI

D
-1

Hydrolytic
tD

ΔM

(days)

(mg.day )

(days)

(%)

Gelapin-2/14.6

1.01 ± 0.06

400 ± 26

3.5 ± 0.5

-2 ± 2

Gelapin-2/19.5

1.0 ± 0.2

320 ± 17

4±0

-2 ± 2

Gelapin-4/4.9

0.07 ± 0.06

520 ± 83

3.5 ± 0.5

+2.5 ± 0.6

Gelapin-4/9.7

0.83 ± 0.09

260 ± 33

5±0

+2.7 ± 0.2

Gelapin-4/14.6

1.3 ± 0.1

180 ± 22

8.5 ± 0.5

+2.3 ± 0.2

Gelapin-4/19.5

2.1 ± 0.3

150 ± 22

10.5 ± 0.5

+2.9 ± 0.3

Gelapin-6/4.9

0.09 ± 0.03

360 ± 25

6±0

+3.9 ± 0.3

Gelapin-6/9.7

0.84 ± 0.07

181 ± 9

11 ± 1

+3.44 ± 0.06

Gelapin-6/14.6

1.4 ± 0.3

120 ± 29

15.5 ± 1.5

+3.3 ± 0.2

Gelapin-6/19.5

1.5 ± 0.3

110 ± 12

17.5 ± 1.5

+5.6 ± 0.5

Gelapin-8/4.9

0.0 ± 0.1

240 ± 28

9.5 ± 0.5

+4.8 ± 0.4

Gelapin-8/9.7

0.73 ± 0.07

140 ± 13

17.5 ± 1.5

+5.9 ± 0.2

Gelapin-8/14.6

1.4 ± 0.2

94 ± 1

22.5 ± 3.5

+6.5 ± 0.4

Gelapin-8/19.5

1.5 ± 0.3

90 ± 12

28.5 ± 3.5

+6.8 ± 0.5

Gelapin-10/4.9

0.0 ± 0.2

210 ± 34

13.5 ± 0.5

+5.9 ± 0.1

Gelapin-10/9.7

0.9 ± 0.2

100 ± 15

29.5 ± 1.5 +7.41 ± 0.07

Gelapin-10/14.6

2.0 ± 0.3

74 ± 9

44 ± 7

+7.9 ± 0.2

60 ± 3

49 ± 3

+9.0 ± 0.3

Gelapin-10/19.5 2.14 ± 0.05
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Figure 2-3: (a) Typical proteolytic degradation profile for Gelapin-8/14.6. (i-iii) indicate the three
period of the degradation, i.e. induction, steady state and tailing, respectively. (b) Proteolytic
degradation rates of Gelapin hydrogels (± SD). (c) Degradation time for Gelapin hydrogels (± ½
range).
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2.3.5

Rheological properties

Strain-sweep experiments were conducted to identify the linear viscoelastic (LVE)
region which was observed to be up to 5% shear strain (data not shown). Hydrogels
which possess a higher cross-linker concentration had shorter LVE regions as
compared with hydrogels with smaller cross-linker concentration, which can be
explained by the stiffening effect of cross-linking. For example, the shear strain
values for the limit LVE region were 5% and 0.1% for Gelapin-4/4.9 and Gelapin8/14.6 hydrogels, respectively. As expected, the values for the storage and loss
moduli were larger for gels with a higher degree of cross-linking, consistent with a
previous rheological study of cross-linked hydrogels using pollock gelatin161. For
example, Gelapin-4/4.9 and Gelapin-8/14.6 hydrogels exhibited storage modulus
values in the LVE region of 9 kPa and 90 kPa, respectively. The data from the
frequency-sweep and creep recovery experiments indicated the storage and loss
moduli of Gelapin hydrogels were independent of frequency up to 80 Hz (data not
shown).
2.3.6

Compressive mechanical properties

The mechanical properties of Gelapin hydrogels were examined in compression
whilst immersed in PBS solution at 37˚C (Figure 2-4). Compressive strain at failure
(εmax) values varied between 50 ± 3% and 74 ± 5% and were inversely proportional
with increasing concentration of genipin (Table 2-2). This can be explained by the
increased density of covalent cross-linking in the hydrogels induced by a higher
genipin concentration – with more covalent cross-links, comes a greater amount of
elastic stiffness reducing the extent of deformation before the hydrogel fails. The
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gelatin concentration was also observed to have a similar effect on εmax values. The
increased gelatin concentration is accompanied by more polymer entanglement
which acts as a comparatively weak cross-link.
Tangent modulus (Etan) values were observed to increase significantly with
increasing concentration of genipin (
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Table 2-2). Etan was also observed to be proportionate to the gelatin concentration. It
is suggested that these observations are a result of increased polymer entanglement
and physical cross-link density. In other words, the gels are becoming stiffer but less
ductile with increasing genipin and gelation concentrations.

Figure 2-4: Typical stress-strain curves for, Gelapin-8/14.6 (line 1), Gelapin-6/9.7 (line 2) and
Gelapin-4/4.9 (line 3).
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Table 2-2: Summary of mechanical properties for Gelapin hydrogels. Compressive strain at failure,
compressive tangent modulus (20%-30% strain), compressive stress at failure and compressive strain
energy to failure are indicated by εmax, Etan, σmax and U, respectively. The nomenclature of Gelapin
hydrogels describes their composition in the format Gelapin-[gelatin %(w/v)]/[genipin %(w/w)].

εmax

Etan

σmax

U

(%)

(kPa)

(kPa)

(kJ/m3)

Gelapin-2/9.7

67 ± 7

13 ± 6

26 ± 6

3±1

Gelapin-2/14.6

57 ± 5

22 ± 4

26 ± 8

3±1

Gelapin-2/19.5

55 ± 7

40 ± 10

27 ± 9

4±1

Gelapin-4/4.9

74 ± 5

18 ± 3

80 ± 40

11 ± 5

Gelapin-4/9.7

59 ± 5

90 ± 20

100 ± 20

16 ± 3

Gelapin-4/14.6

54 ± 2 130 ± 20

110 ± 30

18 ± 4

Gelapin-4/19.5

52 ± 5 160 ± 30

120 ± 30

18 ± 4

Gelapin-6/4.9

65 ± 6

50 ± 10

90 ± 30

14 ± 4

Gelapin-6/9.7

58 ± 5 150 ± 30

180 ± 50

26 ± 7

Gelapin-6/14.6

53 ± 5 200 ± 40

170 ± 70

30 ± 10

Gelapin-6/19.5

51 ± 5 270 ± 40

200 ± 60

30 ± 10

Gelapin-8/4.9

62 ± 5 170 ± 20

230 ± 70

40 ± 10

Gelapin-8/9.7

55 ± 6 250 ± 50 200 ± 100 40 ± 20

Gelapin-8/14.6

52 ± 3 320 ± 30

240 ± 60

38 ± 9

Gelapin-8/19.5

52 ± 5 350 ± 40

270 ± 73

40 ± 10

Gelapin-10/4.9

64 ± 6 160 ± 20

250 ± 90

40 ± 10

Gelapin-10/9.7

62 ± 8 240 ± 40 300 ± 100 50 ± 20

Sample

Gelapin-10/14.6 50 ± 3 380 ± 40

270 ± 60

40 ± 10

Gelapin-10/19.5 51 ± 5 400 ± 50

300 ± 60

50 ± 10
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Compressive stress at failure (σmax) values ranged between 26 ± 6 kPa and 300 ± 60
kPa proportional with the gelatin concentration. It is likely that this can be explained
by realising that gels with higher amounts of gelatin have a higher overall density.
Hence, they require more stress to deformation to the point of failure (Table 2-2).
The cross-linker concentration (genipin) did not have a significant effect on σmax.
Compressive strain energy at failure (U) values ranged from 3 ± 1 kJ/m3 to 50 ± 10
kJ/m3 and increased with increasing gelatin and genipin concentration. The
compressive mechanical characteristics of our gels are in the same order of
magnitude as those reported for a gelatin scaffold (100-140 kPa, cross-linked by
immersion in a genipin solution) developed for cartilage tissue engineering153.
Our results demonstrate that Gelapin hydrogels are a versatile material which can
have tuned mechanical properties through careful control over the gelatin and
genipin concentration. Increasing the gelatin concentration increased the overall
strength and toughness as indicated by the compressive stress and strain energy to
failure, while increasing the genipin concentration increases the stiffness and
toughness and limited the maximum strain attainable which is reflected in the Etan, U
and εmax values.
The effect of degradation on the mechanical characteristics was examined using a
typical Gelapin hydrogel (Gelapin-4/9.7) which was exposed to collagenase for up to
10 days. Figure 2-5 shows strain-at-break values increase, while tangent modulus
values increase during proteolytic degradation of up to 70% (by mass). In other
words, the gels become more ductile and elastic as a result of the mass loss. Once the
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hydrogels had degraded by 70%, they became too fragile to handle and could not be
subjected to mechanical testing.

Figure 2-5: (a) Tangent modulus (20%-30% strain) and (b) compressive stress at failure for typical
Gelapin-4/14.6 hydrogels as a function of mass loss during proteolytic degradation. Arrows indicate
trend with mass loss.
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2.3.7

Angiogenesis

Materials used as a tissue scaffold have traditionally relied upon diffusion of
nutrients and oxygen to provide nourishment and address the respiratory
requirements of the cells therein. However, diffusion is limited to only several
hundred microns in most cases and this presents a challenge for tissue homeostasis14.
This can be overcome by promoting blood vessel invasion into the scaffold27.
Vascularisation of Gelapin hydrogels from existing vasculature was investigated
using the chick embryo CAM as an experimental model of angiogenesis in situ.
Gelapin-6/9.7 hydrogels materials were selected for these studies as gels with this
gelatin concentration (6% w/v) exhibit mechanical properties which are in the middle
of the range of values of the investigated sample compositions (see Table 2-2). Onplants prepared using Gelapin-6/9.7 hydrogel materials in the absence or presence of
the angiogenic stimulator PMA27 were placed on developing chick embryos and
observed for up to 4 days. The presence of the on-plants did not compromise the
viability of the embryos and their ability to grow blood vessels and evidence of blood
vessel intrusion and formation within Gelapin on-plants is shown in Figure 2-6 a-b.
Examination of the area surrounding the on-plants after 4 days of testing revealed
that the number of blood vessels near both the control and PMA containing
hydrogels was 19 ± 1. However, the blood vessels were generally very fine around
the control on-plant and did not appear to extend into the hydrogel (Figure 2-6c). In
contrast, there were also large blood vessels evident in the PMA-containing onplants which intruded into the hydrogel (Figure 2-6 d-f) suggesting that the

80

Gelapin hydrogel acts as a vascularisable soft tissue scaffold for the pro-angiogenic
effect of PMA.

Figure 2-6: Optical images of (a) typical chick embryo after 6 days prior to placement of the Gelapin6/9.7 on-plants, (b) typical chick embryo after 4 days with on-plants prepared in the absence (1) or
presence (2 and 3) of PMA in place, (c) enlargement of control on-plant, (d) enlargement of on-plant 2
prior to excision, and (e-f) enlargements of on-plant 2 after excision showing red blood cells within
the confines of the on-plant.
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2.4

Conclusions

We successfully prepared genipin cross-linked gelatin hydrogel materials which were
characterised in terms of extent of cross-linking, swelling behaviour, degradability
and mechanical characteristics as well as ability for vascularization. It was shown
that soaking Gelapin in phosphate buffered saline solution (37 °C, pH 7.4) for 72
hours resulted in the removal of 99% of the leachable gelatin and genipin. The
swelling behaviour, mechanical properties and degradability of these hydrogels can
be controlled through adjustment of the genipin and the gelatin concentrations. The
degradation rate could be tuned between 50 mg/day and 500 mg/day. Compressive
stress at strain value could be tuned over one order of magnitude (26 ± 6 kPa to 300
± 60 kPa). Proteolytic degradation studies showed that typical Gelapin hydrogels
became more ductile and elastic until they degraded by more than 70% (by mass). It
was shown that typical Gelapin hydrogels have the ability to become vascularised
with incorporation of pro-angiogenic factors. This paper contributes to the
development of Gelapin hydrogels as a potential material for use in future tissue
engineering applications.
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2.5

Supplementary Information

Supplementary Figure 2-1: Schematic of the reaction scheme for the cross-linking of gelatin by
genipin. The abbreviation, LYS, is short for lysine which is the main cross-linkable residue in gelatin.
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Supplementary Table 2-1: The swelling ratio for Gelapin hydrogels after various soaking periods at pH 7.4 and 8.2. The sample naming convention is in the format Gelapin[gelatin %(w/v)]/[genipin %(w/w)]. The dash (-) indicates where a sample has dissolved.

Swelling ratio (%), pH = 7.4
0h

3h

GELAPIN-2/4.9

100

-

-

-

-

-

-

GELAPIN-2/7.3

100

88

-

-

-

-

GELAPIN-2/12.2

100

76

60

40

26

GELAPIN-2/19.5

100

76

60

40

GELAPIN-3/4.9

100

93

-

GELAPIN-3/7.3

100

87

GELAPIN-3/12.2

100

GELAPIN-3/19.5

Swelling ratio (%), pH = 8.2

6 h 12 h 24 h 48 h 72 h 168 h

0h

3h

6h

-

100

-

-

-

-

-

-

-

100

-

-

-

-

-

23

22

22

100

-

-

-

-

-

28

23

23

23

100

83

-

-

-

-

-

-

-

-

-

100

-

-

-

-

-

78

64

48

38

36

35

100

-

-

-

-

-

82

70

54

39

31

29

29

100

88

75

58

39

31

100

77

64

45

32

27

26

26

100

87

75

54

35

-

GELAPIN-4/4.9

100

-

-

-

-

-

-

-

100

-

-

-

-

-

GELAPIN-4/7.3

100

86

77

65

50

40

37

37

100

92

85

75

59

46

84

12 h 24 h 48 h

GELAPIN-4/12.2

100

81

69

54

40

33

31

31

100

89

80

67

50

38

GELAPIN-4/19.5

100

79

66

50

37

30

29

29

100

87

76

62

45

35

GELAPIN-5/4.9

100 100

99

95

90

85

82

81

100

-

-

-

-

-

GELAPIN-5/7.3

100

87

79

67

54

44

41

40

100

93

87

79

66

53

GELAPIN-5/12.2

100

83

72

59

45

36

35

34

100

89

82

71

56

43

GELAPIN-5/19.5

100

81

69

55

42

34

32

32

100

88

78

66

49

38

GELAPIN-10/4.9

100

99

97

95

91

87

86

86

100 105 107

107

105

104

GELAPIN-10/7.3

100

92

86

78

68

58

55

54

100

96

93

88

79

69

GELAPIN-10/12.2 100

90

84

75

63

53

50

48

100

96

92

87

78

67

GELAPIN-10/19.5 100

90

82

72

60

50

46

45

100

94

88

81

69

56
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Supplementary Table 2-2: Gelatin released from Gelapin hydrogels of various compositions after 24
hours of soaking in PBS.

Gelatin released (% total gelatin)
Sample
24h
GELAPIN-2/12.2

-

GELAPIN-2/19.5

-

GELAPIN-3/7.3

0.100 ± 0.001

GELAPIN-3/12.4

-

GELAPIN-3/19.5

-

GELAPIN-4/7.3

0.1 ± 0.001

GELAPIN-4/12.4

-

GELAPIN-4/19.5

-

GELAPIN-5/2.4

0.6 ± 0.01

GELAPIN-5/7.3

0.7 ± 0.02

GELAPIN-5/12.4

-

GELAPIN-5/19.5

-

GELAPIN-10/2.4

1.3 ± 0.03

GELAPIN-10/7.3

0.5 ± 0.01

GELAPIN-10/12.4

0.2 ± 0.004

GELAPIN-10/19.5

-

86

CHAPTER 3: ENHANCED GELATION PROPERTIES OF PURIFIED
GELLAN GUM
Damian Martin Kirchmajer1,2, Benedikt Steinhoff1, Holly Warren1, Ross Clarke3,
Marc in het Panhuis1,2
1

Soft Materials Group, School of Chemistry, University of Wollongong, NSW 2522,

Australia.
2

ARC Centre of Excellence for Electromaterials Science, Intelligent Polymer

Research Institute, AIIM Facility, University of Wollongong, Wollongong, NSW
2522, Australia.
3

CP Kelco, San Diego R&D, 8225 Aero Drive, San Diego, CA 92123, U.S.A.

This chapter was submitted in its current form to Carbohydrate Polymers.
Author statement
Damian M. Kirchmajer performed the majority of the research and wrote the entire
manuscript. Benedikt Steinhoff also performed some experimental research which
contributed to this manuscript. This work would not have been possible without the
intellectual input and support from Holly Warren, Ross Clarke and Marc in het
Panhuis. I would also like to thank Cathy Lancaster for technical assistance.
Primary supervisor confirmation
I, Associate professor Marc in het Panhuis (primary supervisor), support and certify
the above author statement.
Signature:
Date:

87

Abstract
Gellan gum is a hydrogel-forming polysaccharide when combined with monovalent
or divalent cations such as sodium, magnesium, potassium or calcium.
Commercially, gellan gums are sold with trace amounts of these cations which have
been proven to affect the gelation properties and mechanical properties of the
resultant hydrogels. Our research describes a method for purifying gellan gum of
these contaminants. The sodium salt form of gellan gum is shown to have lower
dissolution and gel transition temperatures (the improved gelation behaviour could
have significant benefit in its ability to be utilised as a cell culture or tissue
engineering material as it can be both dissolved and gelled at approximately 37°C).
3.1

Introduction

Gellan gum is a anionic polysaccharide hydrogel-forming polymer produced from
the bacteria Sphingomonas elodea176. Structurally, it comprises a tetrasaccharide
repeat unit of two β-D-glucoses, one β-D-glucuronate, and one α-L-rhamnose120
(Figure 3-1). Gellan gum is available commercially under the trade names GelriteTM
and KelcogelTM in “high acyl” and “low acyl” forms with the high acyl form being
the native state96. The low acyl gellan gum is prepared via alkali treatment of the
native gellan gum and is distinctively different in its gelation behaviour and
mechanical properties279 - high acyl gellan gum will form a gel upon cooling from
65°C creating a flexible, soft hydrogel while low acyl gellan gum will form a gel
upon cooling below 40°C creating a rigid and brittle hydrogel178.
In recent years, low acyl gellan gum has become an attractive biopolymer for
applications in tissue engineering as a cellular scaffold because it resembles the
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natural extracellular matrix (ECM) and is bio-inert51. In particular, gellan gum
hydrogels have been used to encapsulate chondrocytes and were shown to have a
high cellular entrapment efficiency where cell viability and ECM production was
stimulated over a two week period119,188. Gellan gum has also been used as an
injectable matrix for cellular therapies as well where it was remarked that gelation
behaviour permitted cells to be mixed homogenously through the gel solution, then
injected into the body where it formed firm gels within a short time period (~20 s)184.
Gellan gum has also recently been demonstrated to be a material suitable for rapid
prototyping techniques such as 3D gel printing280. Gellan gum microgel suspensions
have been combined with several cell types to create a cellular ink for drop-ondemand cell placement using a microvalve printing approach197. There is therefore
potential for gellan gum based materials to be used for computer aided tissue
engineering, however, this potential may be realised more fully if the gelation
behaviour of gellan gum were improved200. In particular, if the gel transition
temperature were closer to the temperature required to keep cells active and viable
(37°C).

Figure 3-1: The tetrasaccharide repeating unit of acid-form gellan gum. When deacylated, the
indicated acetyl and glyceryl units are removed.
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Gellan gum, like many anionic polysaccharides forms a physical gel by undergoing a
random coil to double helix transition upon cooling120. Stronger gels are formed if
cations are present during the sol-gel transition120. In this case, divalent cations form
particularly strong gels through the aggregation of helixes and monovalent cations
form intermediate strength hydrogels through electrostatic interactions with
carboxylate groups120. The presence of divalent cations also inhibits the ability of the
un-hydrated gellan gum to become hydrated281. In the food industry, it is common
practice to add calcium sequestrants (citrates and phosphates) to water to improve the
ability of low acyl gellan gum to be hydrated282. The presence of cations in
commercially provided gellan gum is ordinarily minimal and may not impede their
use in food and pharmaceutical applications. However, very small amounts of
calcium present in commercial gellan gums may still affect the more sophisticated
chemistries used to modify gellan gum for tissue engineering applications96. Calcium
impurities may also affect the gel transition temperature so significantly that it
precludes it from being utilised in rapid prototyping technology.
A method for the rapid purification of gellan gum was established two decades ago
which employed an ion-exchange resin to capture cationic contaminants present in
commercial gellan gum279,281. They reported that after purifying the gellan gum of
divalent cation contaminants, the acid form gellan gum could be converted to a
monovalent salt using a corresponding hydroxide salt. Sodium or potassium gellanate
salts were able to be hydrated at much lower temperatures and formed gels of
comparable strengths to un-purified gellan gum hydrogels279,281.
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The research reported herein elaborates on Doner’s purification method, and
provides quantitative information regarding the concentration of sodium,
magnesium, potassium and calcium ions before and after purification; the
temperature of hydration and gel transition temperature; and the mechanical
properties of hydrogels prepared from purified and un-purified gellan gum solutions.
In this paper, gels are purified following Doner’s method. We provided for the first
time quantitative information regarding the concentrations of the cation before and
after purification. Furthermore, we present a new method based on impedance
analysis for determining the gel transition temperature of purified and un-purified
gellan gum. Rheological and mechanical compression results are also presented.
3.2

Experiment

All reagents used in these experiments were AR Grade or better with inorganic
contaminants present at 0.01% or lower. Deionised water (DI water) was prepared
using a combination reverse osmosis and ion exchange filter (Millipore, Australia) to
a resistivity of 18.2 MΩ.cm. All glassware was soaked in 10% (v/v) hydrochloric
acid (Ajax Finechem, Australia) for 24 hours prior to use to minimise contamination
of the purified products and also to minimise contamination during inorganic
elemental analysis. Purified gellan gum was prepared from low acyl gellan gum
(GELZAN-CM, Lot #1/1443A, CP Kelco, Singapore) which was generously gifted
from CP Kelco.
3.2.1

Moisture content

The moisture content of un-purified gellan gum was determined using an infrared
moisture determination balance (AD-4712, A&D Company Ltd., Australia). A 5 g
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sample of gellan gum was heated on the balance to 80˚C and weighed periodically
until a steady mass was attained.
3.2.2

FTIR spectroscopy

FTIR spectroscopy of dried samples was performed using a diamond attenuated total
reflectance spectrometer (IRAffinity-1, Shimadzu, Japan) with 2 cm-1 resolution and
Happ-Genzel apodisation.
3.2.3

Purification of gellan gum

Gellan gum (3 g) was dissolved in 300 mL of DI water at 80˚C whilst being stirred
by an overhead mixer (RW 20, IKA, Australia) for 10-15 minutes at 300 rpm. Once
dissolved, the gellan gum solution was cooled to 60˚C before adding 8 g of cation
exchange resin (50WX8 DOWEX, Sigma Aldrich, USA). The mixture was stirred
for 30 minutes at 60˚C before stirring was stopped and the resin was allowed to
settle. The supernatant was then decanted and filtered (grade 165, Filtech, Australia)
into a chilled reservoir containing 300 mL of 2-propanol (Ajax Finechem, Australia)
with rapid stirring whereupon fibrous agglomerates of acid-form gellan gum (A-GG)
precipitated. The A-GG was recovered from the 2-propanol solution using vacuum
assisted filtration and freeze-dried (Alpha 1-2LDplus, Christ, Germany) for 48 hours
to remove residual water and 2-propanol.
The purified gellan gum sodium salt (Na-GG) was prepared in the same manner
described above excepting that the supernatant, after being decanted, was neutralised
with ~10 mL 0.4 M standardised NaOH solution until the pH of the solution reached
7.4 (826 pH-Mobile pH meter, Metrohm, Australia). After being neutralised, the
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supernatant was precipitated into 2-propanol and freeze dried as previously
described.
3.2.4

Atomic absorption spectroscopy

Atomic absorption spectrometry of gellan gum samples was performed using a flame
atomisation atomic absorption spectrometer (flame-AAS, Spectra AA 220FS, Varian,
Australia) with hollow cathode lamp light sources for sodium (589.6 nm), potassium
(769.9 nm), calcium (422.7 nm) and magnesium (285.2 nm), and an air/acetylene
oxidant/fuel mixture.
Samples, blanks and calibration standards were prepared with a 5% (v/v) sulfuric
acid matrix with CsCl (Sigma Aldrich, USA) added as ionisation suppressant.
Calibration standards were prepared from certified multi-element standard solution
(Lot #A2-MEB2366019, Inorganic Ventures, Australia). Samples were digested prior
to analysis as follows: Approximately 1.00 g of sample was weighed and transferred
quantitatively into a 150 mL Erlenmeyer flask. 5.0 mL of concentrated sulfuric acid
(Ajax Finechem, Australia) was then added, followed by heating until the solids
dissolved and the solution turned dark brown and started to fume. Hydrogen peroxide
(30% v/v, Ajax Finechem, Australia) was then added drop-wise until the solution
turned clear. The solution was then allowed to cool to room temperature before
having 16 mL of 12.6 mg/mL CsCl solution was added. The solution was then
diluted to 100 mL with DI water, mixed thoroughly, and measured within the day.
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3.2.5

Gel transition temperature

The gel transition temperature for solutions of GG and Na-GG was assessed using a
custom-designed electrical impedance instrument as well as a rheometer (Physica
MCR-301, Anton Paar, Australia) in rotation mode. For electrical impedance
analysis, hot gel solutions were poured into rectangular plastic troughs (1 cm x 1 cm
x 4.5 cm) with reticulated vitreous carbon electrodes (ERG Aerospace, USA) placed
at either end such that the distance between the electrodes was 2.5 cm. The
impedance analysis was performed by applying 1 V peak voltage and alternating
current signals from a waveform generator (U2761A, Agilent, USA) to a circuit
comprised of the gel sample cell and a 10 kΩ resistor in series while the temperature
was measured simultaneously with a digital thermometer probe (Jaycar Electronics,
Australia). Impedance across the gel sample cell for frequencies ranging from 100
Hz to 100 kHz were measured as the gel cooled using an oscilloscope (U2701A,
Agilent, USA). The gel transition temperature is defined as the point where the slope
of the impedance divided by the temperature of the gel changes from one constant to
another.
For rheometry based measurements, hot gel solution was sandwiched between a
temperature controlled stage (Jaluba, AWC 100) and 50 mm diameter and 1° cone
(CP50-1, Anton Paar, Australia) with a gap length of 0.097 mm. The sample was
then sheared in rotation at a shear rate of 100 s-1, while the temperature controlled
stage was cooled from 70°C to 20°C at a rate of 5°C.min-1. The temperature of
gelation was determined graphically, as the temperature at the point where viscosity
started the increase dramatically.
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3.2.6

Compressive mechanical analysis

Hydrogel samples for mechanical analysis were prepared by dissolving gellan gum in
DI water at 80°C for 30 minutes with gentle stirring followed by addition of 1 M
NaCl solution to a concentration of 100 mM or 0.5 M CaCl2 solution to a
concentration of 5 mM. The hot gel solutions were then poured into moulds (17.5
mm diameter x 10 mm high, PVC rings) and cooled to 21°C to form firm hydrogels.
Samples were compressed at a rate of 1 mm.min-1 at 21˚C using a universal
mechanical testing apparatus (EZ-S, Shimadzu, Japan). The resulting stress-strain
data was used to determine the compressive failure strain (εc), compressive secant
modulus over 20% - 30% strain (Ec), compressive failure stress (σc) and compressive
strain energy to failure (U).
The swelling ratios (SW) of hydrogels were calculated as the mass of the swollen
hydrogel (ms) divided by the mass of the dried hydrogel (md).

.

3.2.7

(1)

Statistical treatment of data

Unless otherwise stated, the errors presented herein are the standard deviation of at
least three measurements.
3.3
3.3.1

Results
Purification of gellan gum

As supplied, the un-purified gellan gum (GG) was a beige coloured powder which
dissolved slowly at a concentration of 1% (w/v) at 80°C in DI water to a produce
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clear, pale yellow solution from which hydrogels of gellan gum could be prepared by
cooling the solution to room temperature (21°C). The moisture content of un-purified
GG was found to be 1.1 ± 0.2%.
A procedure based on the method described by Doner281 was used to purify the
gellan gum to produce the acid-form gellan gum (A-GG) with an average yield of 58
± 2%. After drying, the A-GG was in the form of a dry, paper-like fibrous mat which
was beige in colour. The solubility of the A-GG in DI water was especially poor and
would not dissolve at a concentration of 1% (w/v) at 80°C like GG did. We suggest
that this may be because the neutral acid form of gellan gum is less polar than the
carboxylate salt form which is present to some extent in commercial gellan gum.
Review of the FTIR spectra of GG and A-GG indicates that the peak at 1740 cm-1 is
only apparent in the A-GG spectrum which is typical of the carbonyl stretching mode
of carboxylic acids. This peak is replaced by one at 1600 cm-1 in the GG and Na-GG
spectra which is typical of the carbonyl stretching mode of a deprotonated carboxylic
acid. This suggests that during the purification process, GG became acidified and the
cations were stripped away from the carboxylate groups (Figure 3-2). This
hypothesis is also supported by the observation that addition of a small amount of
sodium hydroxide (which changes the acid form gellan gum to the sodium
carboxylate salt of gellan gum) drastically improved the solubility and clarity of AGG solutions.
Acid-base titration of A-GG using standardised potassium hydroxide solution (0.01
M, Sigma Aldrich, USA) were conducted to determine the number of cation binding
sites available to interact with cations such as Na+, Mg2+, K+ and Ca2+. The number
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of cation binding sites was determined to be 1.27 ± 0.08 mmol.g-1 which is
marginally less than the theoretical number cation binding sites (1.55 mmol.g-1).
The purified sodium salt form gellan gum (Na-GG) was prepared with an average
yield of 64 ± 6%. In contrast to A-GG, the dried product was bright white and
dissolved very quickly and easily at a concentration of 1% (w/v) at 80°C.

Figure 3-2: ATR-FTIR spectra of GG, Na-GG and A-GG.

3.3.2

Elemental analysis of impurities

Elemental analysis of A-GG indicates that the purification method effectively
removed Na, Mg, K and Ca from GG. The concentration of Na, Mg, K and Ca in
GG, A-GG and Na-GG were measured using Flame-AAS (Table 3-1). The analysis
revealed that an appreciable amount of Na, K and Ca was present in the commercial
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GG which accounts for approximately 6.4% of the dry weight of GG and would be
expected to occupy a large proportion of the available cation binding sites. Of
particular significance is the concentration of Ca in commercial GG (0.34 ± 0.06
mmol.g-1) which is known to form strong associations with the cation binding sites in
gellan gum120.
The concentration of Na, Mg, K and Ca present in the A-GG and Na-GG samples
were significantly lower than those found in GG (Table 3-1) which attests to the
efficacy of the purification methods. The concentration of Mg and Ca in A-GG and
Na-GG were both reduced to below the limit of detection for the method (0.013
mmol(Mg).g-1 and 0.01 mmol(Ca).g-1, respectively). With respect to Na-GG, Mg2+
and Ca2+ were replaced mainly by Na+ and to a smaller extent K+; the aggregated
concentration of Na and K (1.35 ± 0.05 mmol.g-1) approximately equals the
previously measured number of cation binding sites (1.27 ± 0.08 mmol.g-1).
Table 3-1: Concentration of metal cations in GG, A-GG and Na-GG (±SD). *These concentrations
were below the limit of detection for these elements.

Concentration

GG

A-GG

mmol (Na).g-1

0.24 ± 0.06

mmol (Mg).g-1

0.048 ± 0.003

mmol (K).g-1

1.14 ± 0.01

mmol (Ca).g-1

0.34 ± 0.6

Na-GG

0.0044 ± 0.0004 1.09 ± 0.04
< 0.013*

< 0.013*

0.0240 ± 0.0006 0.26 ± 0.03
< 0.01*
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< 0.01*

3.3.3

Dissolution and gel transition temperatures

Purified Na-GG was observed to dissolve at lower temperature than GG or A-GG.
The temperature at which 1% (w/v) mixtures of GG, A-GG and Na-GG would
dissolve was examined by slowly warming the mixtures from 5°C to the temperature
where solutions ceased to be turbid. According to technical data from CP Kelco178,
GG requires heating to approximately 80°C for full dissolution4, however we
observed that the 1% (w/v) solution of GG went from turbid to clear at a temperature
of 57 ± 3°C. A-GG was observed to be completely insoluble even at temperatures up
to 90°C; this observation was also noted in Doner’s previous experiments279,281. It
was possible to prepare a clear solution of A-GG by boiling at ~ 96°C, however it is
likely this occurred because the gellan gum was depolymerising to a lower molecular
weight. Na-GG was observed to dissolve at a temperature of 39 ± 4°C which,
incidentally, is very close to the optimal temperature for mammalian cell culture
(37°C).
The gel transition temperature of Na-GG was observed to be lower than that of GG,
regardless of the cross-linking cation used. Samples which were cross-linked with
100 mM sodium possessed the highest gel transition temperature of 46 ± 2°C and 45
± 2°C for GG and Na-GG, respectively. Gellan gums which were cross-linked with 5
mM calcium possessed an intermediate gel transition temperature of 37 ± 2°C and 36
± 2°C for GG and Na-GG, respectively. Gellan gums which were not cross-linked
with cations also exhibited a gel transition at 30 ± 2°C and 29 ± 2°C (GG and NaGG, respectively).
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A new method using a custom-designed electrical impedance apparatus was used for
determining the gel transition temperature of 1% (w/v) GG and Na-GG with no
added cross-linker, 100 mM Na+, and 5 mM Ca2+ (these concentrations are typical
cross-linker concentrations for the formation of firm gellan gum hydrogels 120,177). In
this method, a gel solution was placed in between two electrodes and slowly cooled
while the electrical impedance and temperature were measured simultaneously. As
the solution cools, the ion mobility decreased and the electrical impedance increased
at a linear rate. The gelation event is apparent by a distinct change in the rate of
change of electrical impedance (Figure 3-3a). Using this method, the temperature of
gelation for 1% (w/v) Na+ and Ca2+ cross-linked GG and Na-GG were determined
(Table 3-2). For comparison, the gel transition temperature was also measured using
a rheometry based method. In the rheometric analysis, samples of gel solution were
sandwiched between a temperature controlled stage and a rotating cone. While the
temperature dropped, the viscosity of the gel solution was measured and the gelation
event was apparent when the viscosity increased dramatically (Figure 3-3b). There
was excellent agreement between the two methods (Table 3-2). This indicates the
validity of the impedance method.
We thus suggest that hypothetically, a solution containing of Na-GG and cells
(possibly in conjunction with other materials) could be used to create a “cellular ink”
that could be extruded to create complex 3D structures with potential application in
tissue engineering/organ printing.
Another advantage of Na-GG is that it makes its carboxylic acid groups more
accessible, which could be used to functionalise the gellan, for example, with the
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integrin binding RGD sequence using EDC chemistry. This strategy has been shown
previously to enhance cellular adhesion to gellan gum matrixes but has a low
functionalization efficiency due to the poor access to carboxylic acid groups96,283.

Figure 3-3: Gel transition temperature determinations of a typical Na-GG solution cross-linked with 5
mM Ca2+. a) Average electrical impedance between 100 Hz and 100 kHz as a function of temperature
b) viscosity at 100 s-1 as a function of temperature. Straight lines are linear fits of the data.
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Table 3-2: Gel transition temperatures of GG and Na-GG with either Na+, Ca2+ or no cross-linking
ions. Timpedance and Trheometric indicate the gel transition temperatures determined using the electrical
impedance method and rheometric method, respectively. *T impedance could not be determined for those
samples as the gel transition temperature was below the minimum measureable temperature.

Cross-linker Timpedance Trheometric

3.3.4

GG

None

*

29.5 ± 2

GG

Na+

44 ± 1

46 ± 2

GG

Ca2+

37 ± 1

37 ± 2

Na-GG

None

*

28.5 ± 2

Na-GG

Na+

44 ± 3

45 ± 2

Na-GG

Ca2+

36 ± 1

35.5 ± 2

Mechanical analysis

Hydrogels prepared from Na-GG were observed to be weaker and less stiff than
those prepared from GG. The mechanical properties of hydrogels prepared from 1%
(w/v) solutions GG and Na-GG which were cross-linked with either 100 mM Na+ or
5 mM Ca2+ were examined using compressive mechanical analyses (swelling ratio of
all hydrogels was 101). Calcium cross-linked hydrogels were observed to have
higher compressive stress to failure and secant moduli than sodium cross-linked
hydrogels for both purified and un-purified gellan gums (Table 3-3). In Doner’s
previous report281, it was remarked that hydrogels prepared from the purified Na-GG
were of comparable strength to the un-purified gellan gum. However, Doner used
different brands/grades of gellan gum (Phytagel from Sigma Chemical Company and
GelGro from ICN Biochemicals) which may have had different degrees of
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acetylation and molecular weights which would be expected to effect the gelation
behaviour and gel strength281. Also, the cross-linker concentrations stated are the
nominal concentrations resulting from direct addition of Na+ or Ca2+ solution; the
concentration of Na+ and Ca2+ which were already present in GG were not taken into
consideration for these measurements.
Table 3-3: Compressive mechanical properties of hydrogels prepared from GG and Na-GG (100 mM
Na+ and 5 mM Ca2+ nominal cross-linker concentrations were used). SW – swelling ratio, εc compressive failure strain, Ec - compressive secant modulus over 20%-30% strain, σc - compressive
failure stress and U - compressive strain energy to failure, *where samples fractured for less than 30%
strain, the average modulus over 0-25% strain is presented.

SW

εc

Ec

U

(kPa)

(%)

(kPa)

(kJ.m-3)

GG (Na+ cross-linked)

101

34 ± 3 114 ± 5

4±1

GG (Ca2+ cross-linked)

101 130 ± 20 61 ± 3 108 ± 2

28 ± 4

Na-GG (Na+ cross-linked)

3.4

σc

30 ± 5

101

10 ± 1

35 ± 2

41 ± 2

1.5 ± 0.2

Na-GG (Ca2+ cross-linked) 101

19 ± 1

25 ± 1 78 ± 3* 2.3 ± 0.2

Conclusions

Commercial gellan gum (GG) was shown to possess inorganic contaminants which
affected its dissolution and gelation behaviour as well as the mechanical properties of
resultant hydrogels.

Purified gellan gum (Na-GG) was dissolved fully at

approximately 39 ± 4°C and could form a firm hydrogel at approximately the same
temperature (36 ± 2°C) in the presence of Ca2+ ions. These temperatures coincide
with the temperature required for cell culture (37°C). A new impedance method for
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determination of gel transition temperature was validated in this research. It should
be noted that a deeper investigation of the imaginary component of the impedance
spectrum might provide further insight into the electrical properties of this material
and others and should be considered in future work. This paper contributes to the
development of gellan gum as a material for tissue engineering applications.
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Abstract
We report the development of a robust biopolymer based ionic-covalent
entanglement network hydrogel made from calcium cross-linked gellan gum and
genipin cross-linked gelatin. The ratio of the two polymers and the cross-linker
concentrations significantly affected the mechanical characteristics of the hydrogels.
Hydrogels with optimized composition exhibited compressive fracture stress and
work of extension values of up to 1.1 ± 0.2 MPa and 230 ± 40 kJ.m-3 for swelling
ratios of 37.4 ± 0.6 and 19 ± 1, respectively. The compressive and tensile mechanical
properties, swelling behaviour (including leachage), pH sensitivity and homogeneity
are discussed in detail. Fully swollen hydrogels (swelling ratio of 37.4 ± 0.6) were
able to recover 95 ± 2% and 82 ± 7% of their energy dissipation (hysteresis) at 37 °C
after reloading to either constant stress (150 kPa) or constant strain (50%),
respectively.

4.1

Introduction

Hydrogels are highly swollen, materials prepared from hydrophilic polymers that can
absorb up to a thousand times their dry weight in water40. As a result of their high
water content, most hydrogels are soft and weak materials compared to other
polymeric materials such as rubbers. For this reason, hydrogels are typically utilised
for applications which do not require them to be particularly strong or resilient (for
example, in foods, ointments and creams)40,139,284. As soft and wet materials,
hydrogels are a substance that is reminiscent of soft biological tissue and have been
investigated over the past 30 years as candidate materials for soft tissue engineering
scaffolds2,34,40,139. However, new applications of hydrogels such as soft robotics285–287
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and cartilage tissue scaffolds288 require hydrogels with enhanced mechanical
performance which has stimulated an investigation into how hydrogels may be made
tougher and more enduring68,239,241,289.
Tough hydrogels have been prepared using methods such as slip-ring hydrogel
synthesis, nano-composite hydrogels, and double network hydrogels239,242,289–292. Of
all the tough hydrogel synthetic strategies, the double network approach affords the
highest versatility in terms of composition and resulting properties242. Double
network (DN) hydrogels are interpenetrating polymer networks (IPN) which are
formed in a two-step synthesis where a highly cross-linked, rigid and brittle
polyelectrolyte is swollen in a monomer solution of a ductile, neutral polymer that it
is subsequently polymerised241,242. This approach has been recently adapted for the
formation of tough, IPN hydrogels in a “one-pot” synthetic approach243,290,292–294.
These new hydrogels referred to as ionic-covalent entanglement (ICE) network
hydrogels consist of a tough and self-recovering, interpenetrating network of an
ionotropic polymer and a chemically cross-linkable polymer68,69,245. ICE network
hydrogels prepared from gellan gum and PAAm possessed compressive strain energy
to failure of 44 kJ.m-3 and were able to recover 53% of their hysteresis (within 1
hour) when compressed to a constant stress (25 kPa) at 21 °C

69

. ICE network

hydrogels made from alginate and PAAm were able to be stretched a phenomenal 23
times their original length and resulting in fracture energies of 9000 J.m -2

68

. They

were able to recover up to 74% of their hysteresis (upon stretching to a constant
strain) when rested for 1 day at 80 °C. Recently, we demonstrated that the ICE
approach can be adapted for printing these alginate-PAAm tough gels246.
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Gellan gum is an anionic polysaccharide biopolymer derived from the bacteria
Pseudomonas elodea176. It comprises a tetrasaccharide repeating unit structure of βD-glucose, β-D-glucuronic acid and α-L-rhamnose with varying degrees of
acetylation. Low-acyl gellan gum is a polymer which gels ionotropically in the
presence of cations when its temperature is reduced below the coil-helix transition
temperaure120. Gellan gum has been used as a food additive for a long time and
recently, as a material for biomedical applications such as cartilage tissue
engineering and as an injectable, in situ forming hydrogel polymer for cellular
delivery119,120,184.
Gelatin is a denatured and partially hydrolysed protein produced from collagen – a
biopolymer present in almost all connective tissue in the human body258. Gelatin is a
highly versatile biopolymer which can be obtained from a variety of animal sources,
is cheap, and can be produced at a range of isoelectric points, molecular weights and
gel strengths258. It has been used in biomedical devices, pharmaceuticals and tissue
engineering for over fifty years, is biocompatible, non-cytotoxic, non-immunogenic
and presents no risk of pathogen transfer from originating organism unlike its parent
protein collagen104,117,144,146,147,152,172,257,259,261,295–297. Without cross-linking, gelatin
hydrogels are very weak and readily dissolve at temperatures above 29˚C which
prohibit their use in tissue engineering54,158. However, covalent cross-linking
significantly improves the mechanical performance and stability of gelatin
hydrogels162,260.
Genipin is the algycone of geniposide, an iridoid glycoside that is the major
component of the fruit of the gardenia plant, Gardenia jasmindides Ellis and is
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emerging as a popular chemical cross-linker of choice for proteinaceous biopolymers
such as gelatin, collagen and chitosan46,163. Genipin forms chemical cross-links
between primary amino groups present in either the ε-amino groups of lysine and
hydroxylysine residues, or the guanidinium group of arginine residues in
gelatin162,167,260. Genipin has been reported to be a non-cytotoxic cross-linker and
anti-inflammatory agent46,164–166 and has been used to prepared scaffolds for tissue
engineering and materials for biomedical engineering applications over the past 68
years103,104,147,153–156,298,299.
In this paper, we report the preparation of a new type of ICE network hydrogel based
on the biopolymers gellan gum (calcium cross-linked) and gelatin (genipin crosslinked). We investigated the mechanical properties in compression and tension as
well as in “as prepared” state and equilibrium swollen state. The behaviour of the
hydrogels when immersed in simulated body fluid was also investigated with respect
to polymer leaching, cation migration, pH and dimensional changes. Finally, the
ability of these hydrogels to dissipate energy after repeated compressions with
different length resting periods in ambient conditions and simulated body fluid at 37
°C was examined.
4.2
4.2.1

Experimental section
Materials

All reagents used were AR grade unless otherwise stated and deionised (DI) water
was prepared using a combined ion exchange and osmosis filtration system
(Millipore, Australia) to a resistivity 18.2 MΩ cm. Low acyl gellan gum (Lot
#1/1443A, Gelzan-CM, CP Kelco, Singapore) and type A, porcine gelatin (Bloom
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number 300, molecular weight 87.5 kDa, Sigma Aldrich, USA) were used to
prepared hydrogels. A 20.3% (w/v) genipin (Challenge Bioproducts, Taiwan)
solution in 60% (v/v) ethanol (Ajax Finechem, Australia) was used for cross-linking
gelatin and a 1 M CaCl2 (Sigma Aldrich, Australia) solution was used for crosslinking gellan gum.
Simulated body fluid (SBF) was prepared with DI water and contained 0.035% (w/v)
NaHCO3; 0.0548% (w/v) MgCl2.6H2O; 2% (v/v) HCl; 0.02% (w/v) NaN3; 0.80%
(w/v) NaCl; 0.0224% (w/v) KCl; 0.0174% (w/v) KH2PO4; 0.0368% (w/v)
CaCl2.2H2O;

0.0071%

(w/v)

Na2SO4;

and

0.606%

(w/v)

tris(hydroxymethyl)aminomethane (Chem-Supply, Ajax Finechem, and Sigma
Aldrich, Australia). The pH of SBF was adjusted to 7.4 ± 0.2 at 37˚C using 1 M
NaOH solution and pH meter (826 pH Mobile, Metrohm, Australia).
4.2.2

Hydrogel preparation

Hydrogels were prepared as follows: gellan gum was added to 80˚C DI water with
rapid stirring until dissolved on a hot plate/stirrer (CB162, Stuart, UK). Gelatin was
then added and stirred until dissolved. Subsequently, 1 M CaCl2 solution and 20.3%
(w/v) genipin solution was added to reach the desired cross-linker concentrations.
The solutions were then stirred for 3 more minutes before being poured into glass
petri dish moulds (60 mm diameter x 15 mm height, Schott, Australia) and left to
cure for 24 hours, covered at 21 ± 5˚C.
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4.2.3

Mechanical analysis

Mechanical analyses were performed using a universal mechanical testing apparatus
(EZ-S, Shimadzu, Japan). For compressive mechanical analysis, samples were cut
from slabs of hydrogel into rectangular prisms 10 mm x 10 mm x 7 mm, and
subsequently compressed at a rate of 1 mm.min-1 at 21˚C. The resulting stress-strain
data was used to determine the compressive failure strain (εc), compressive secant
modulus over 20%-30% strain (Ec), compressive failure stress (σc) and compressive
strain energy to failure (U).
For tensile mechanical analysis, samples were cut with a “dog-bone” shaped cutter
(conforming with JIS – K6250300) with a thickness of 1.7 mm, neck width of 4 mm
and gauge length of 50 mm, and subsequently pulled at a rate of 4 mm.min-1 at 21˚C.
The resulting stress-strain data was used to determine the elongation to failure (εt),
Young’s modulus (Et), tensile fracture stress (σt) and work of extension (W).
Trouser tear tests based on the Japanese Industrial Standard method were used for
fracture analysis301. Trouser shaped samples were cut with a steel cutter 1.7 mm thick
(T), 50 mm long and 4 mm wide with a 25 mm split length. The legs of the trousers
were pulled in tension perpendicular to the direction of crack propagation (mode III
tearing) at a rate of 4 mm.min-1 and at 21˚C. The critical fracture energy (Gc) was
calculated as follows:

,

(1)

where F was the force require to propagate the crack in a hydrogel.
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Recovery of hysteresis behaviour of swollen hydrogels was examined in
compression to either a specific stress, or to a specific strain value. Samples of the
hydrogels were prepared in disc moulds (17.5 mm diameter, 5 mm height) and then
immersed in SBF for 3 days at 37˚C to allow them to reach their equilibrium swollen
state. The hydrogels were then loaded in compression at a rate of 1 mm.min-1 until
they reached either a stress of 150 kPa, or strain of 50% and then unloaded at a rate
of 1mm.min-1 to the original height. Samples were then subjected to up to 4
subsequent loading and unloading cycles after a period of resting in SBF at 37˚C
(wet recovery) or wrapped in plastic wrap (Gladwrap, Clorox Australia Pty Limited,
Australia) at 37˚C (dry recovery). The energy dissipated during a cycle (hysteresis,
U) was calculated using

,

(2)

where σ and ε are the compressive stress and strain during cycle i.
4.2.4

Optical microscopy

The homogeneity of the hydrogels was examined using light microscopy (Z16,
Leica, Germany) of hydrogels which had been paraffin embedded, sectioned and
stained using periodic acid-Schiff (PAS) staining302. The hydrogels were first
embedded using automated tissue processing and embedding stations (ASP200S,
EG1150C and EG1150H, Leica, Germany) which dehydrated the hydrogels using a
solvent gradient of 70% (v/v) ethanol, 90% (v/v) ethanol, absolute ethanol and
xylene before embedding in paraffin. The gels were then sectioned using a
microtome (RM2255, Leica, Germany) to a thickness of 10 μm and collected on
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glass microscopy slides (Knittel, Germany). The hydrogel sections were then rehydrated using the reverse of the abovementioned solvent gradient; oxidised with 5%
(w/v) periodic acid (BDH, England) for 5 minutes; and stained with Schiff’s Reagent
(Merck, USA) for 15 minutes before being dehydrated using an automated staining
station (ST4020, Lecia, Germany).
4.2.5

FTIR spectroscopy

The connectivity between gellan gum and gelatin polymer networks in the hydrogels
was examined using Fourier transform infrared spectrometry (IRAffinity-1,
Shimadzu, Australia). Hydrogel samples were oven dried (FD, Binder, USA) at 80 ±
5˚C ˚C for 4 hours prior to analysis with a diamond ATR accessory. The spectra
were processed using Happ-Genzel apodisation, ATR correction, smoothing and
baseline correction algorithms.
4.2.6

Immersion studies

Gels were immersed in SBF at 37 ± 1˚C in a temperature controlled chamber
(Thermoline, Australia) for 148 hours. The swelling ratio of the hydrogels as well as
the pH and gellan gum, gelatin, sodium, magnesium, potassium and calcium
concentrations in the immersion solutions were measured at 0, 3, 6, 12, 24, 48, 72,
96, 120 and 144 hours.
Gelatin and gellan gum concentrations were measured with a Coomassie Plus assay
(Thermo Scientific, Australia) and a Total Carbohydrates assay (Biovision
Incorporated, USA), respectively, in microplate format using a plate reading
spectrophotometer (Polarstar, BMG Labtech, Germany).
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The sodium, magnesium, potassium and calcium concentration of the immersion
solutions was measured using inductively coupled plasma mass spectrometry
(7500CE, Agilent Technologies, Japan). The element concentrations were
determined using standard curves based on

23

Na,

25

Mg,

39

K and

48

Ca isotopes.

Samples were prepared for analysis by diluting to the working ranges of the standard
curves with high purity DI water containing 2% (v/v) HNO3 (Suprapur, Merck
Millipore, Australia). Calibration standards were prepared from a certified multielement standard (Lot# A2-MEB236019, Inorganic Ventures, Australia) in 2% (v/v)
HNO3. High purity argon was used as the plasma/carrier gas and helium was used as
the collision/reaction gas.
The swelling ratio (SW) was calculated as the mass of the swollen hydrogels (ms)
divided by the dry mass (md). Swollen hydrogel mass measurements were taken on a
top-loading balance (PB3002/-S/FACT, Metler-Toledo, Australia) after the gels were
extricated from the immersion solutions and blotted dry with filter paper (165
hardened and ashless papers, Filtech, Australia).
The effect of pH on the SW of hydrogel was studies by immersing the hydrogels in
0.1 M phosphate buffered saline (PBS) solution for 24 hours. The pH of all
immersion solutions was measured with an electrode based pH meter (826 pH
Mobile, Metrohm, Australia).
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4.2.7

Statistical treatment of data

Dixon’s Q-test (95% confidence) was used to confirm and justify the removal of
spurious data. Unless otherwise stated, the data presented in this manuscript are the
mean ± one standard deviation (SD).
4.3
4.3.1

Results
Optimisation of hydrogel composition

Ionic-covalent entanglement network hydrogels (Figure 4-1) were prepared from
calcium cross-linked gellan gum and genipin cross-linked gelatin. The values of the
mechanical properties exhibited by the ICE gels is better than the sum of its
constituent gel materials, i.e. hydrogels comprising of only calcium cross-linked
gellan gum, or only genipin cross-linked gelatin (Figure 4-2, Table 4-1).

Figure 4-1: Photographs of typical a typical ICE network hydrogel (2.75% w/v polymer) subjected to
tensile (a) and trouser tear (b) tests.
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Table 4-1. Mechanical properties of ICE network, gellan gum and gelatin hydrogels with varying
polymer concentrations (± SD).

ICE

ICE

ICE

network

network

network

(2.75% wt)

(4.12% wt)

(5.50% wt)

σc (kPa)

1100 ± 200

1000 ± 200

εc (%)

85 ± 1

Ec (kPa)

Gellan gum

Gelatin

(1% wt)

(1.75% wt)

1000 ± 200

360 ± 80

20 ± 10

81 ± 5

72 ± 3

82 ± 2

74 ± 5

120 ± 20

260 ± 30

490 ± 30

70 ± 10

4.5 ± 0.6

U (kJ.m-3)

147 ± 9

200 ± 40

200 ± 40

57 ± 7

3±1

σt (kPa)

270 ± 20

510 ± 30

620 ± 60

70 ± 10

*

εt (%)

64 ± 4

66 ± 6

69 ± 3

16 ± 2

*

Et (kPa)

420 ± 20

780 ± 30

890 ± 50

460 ± 30

*

W(kJ.m-3)

80 ± 10

170 ± 30

230 ± 40

6±2

*

Gc (J.m-2)

40 ± 10

98 ± 4

126 ± 6

*

*

SW

40 ± 5

25 ± 5

23 ± 5

101 ± 5

58 ± 3

εc compressive failure strain; Ec compressive secant modulus; σc compressive failure stress; U
compressive strain energy to failure; εt elongation to failure; Et Young’s modulus; σt tensile fracture
stress; W work of extension; Gc critical fracture energy; SW swelling ratio. Properties marked with
“*” were unable to be determined because the hydrogel samples were too fragile to undergo testing.
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Figure 4-2: Compressive stress-strain of a typical ICE network hydrogel (2.75% w/v polymer) and its
constituent gellan gum and gelatin hydrogel components.

Gels of various compositions were examined to determine the optimum polymer and
cross-linker ratios in terms of mechanical characteristics. For example, the polymer
ratio was changed by increasing the gelatin content while keeping the amount of
gellan gum constant. The compressive stress at failure reached a maximum of 1.1 ±
0.2 MPa for ICE network consisting of 36% (w/w) gellan gum to 64% (w/w) gelatin
(Figure 4-3a). A similar trend was observed for compressive strain energy to failure
(Supplementary Figure 4-1, Supplementary Table 4-1), while secant modulus
increased with gelatin content (Figure 4-3b). Similar trends were observed for the
ratio between Ca2+ cross-linker and gellan gum (Figure 4-3c-d, Supplementary
Figure 4-2, Supplementary Table 4-2). In contrast, changing the ratio of the genipin
to gelatin did not result in a maximum (Supplementary Figure 4-3, Supplementary
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Table 4-3). Rather, compressive stress to failure and compressive strain energy
increase, while the compressive secant modulus decreases with increasing genipin to
gelatin ratio. It is not clear at present why some of the mechanical characteristics
decrease with this increasing ratio. However, this result appears to suggest that gellan
gum network may impede the formation of covalent cross-links in the gelatin
network due to a shielding effect.
The distribution of gellan gum and gelatin throughout the hydrogels was confirmed
to be homogenous based on microscopic investigations of stained hydrogel sections.
Gelatin was stained blue from the genipin170, and gellan gum was stained pink using
periodic acid-Schiff (PAS) staining. There were no distinct blue (gelatin rich) regions
or pink (gellan gum rich) regions in the micrographs (Figure 4-4a).

Figure 4-3: Compressive mechanical stress at failure and compressive secant modulus of gellan gumgelatin ICE network hydrogels with: a, b) varying polymer ratios (changed by increasing gelatin
content while keeping gellan gum content constant) with constant cross-linker concentrations; c-d)
Varying Ca2+ concentration with constant polymer and genipin concentrations.
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FTIR spectroscopy suggested that the gellan gum and gelatin polymer networks were
not covalently cross-linked. FTIR spectra of the gellan gum-gelatin ICE network
hydrogels were observed to be a simple combination of the spectra of gellan gum
hydrogels and gelatin hydrogels spectra (Figure 4-4b). This indicates that no new
covalent bonds were formed or existing covalent bonds were broken during the
preparation of ICE network hydrogels. This strongly suggests that the two polymer
networks are covalently independent of one another.

Figure 4-4: a) Micrograph of a gellan gum-gelatin ICE network hydrogel which has been sectioned
and stained. b) FTIR spectra of gellan gum, gelatin and gellan gum-gelatin ICE network hydrogels.

The mechanical properties were also investigated by testing the most robust
hydrogels in tension (Table 4-1). It is well known that mechanical properties such as
fracture energy (Gc) and Young’s modulus (E) values increase with decreasing
swelling ratio. Figure 4-5a shows that the Gc and E values of our gels are smaller
than those of DN gels and rubbers, but larger compared to conventional gels. It is
likely that the difference in Gc values between DN and our ICE gels can be
(partially) attributed to the difference in swelling ratio. Our ICE gels have swelling
ratios of 20-40, which is larger than the corresponding ratios for DN gels (< 10).
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However, comparing gels at similar swelling ratios (20-40) reveals that the work of
extension values (W) of our gels is better than those of conventional gels, but not as
good as NC hydrogels (Figure 4-5b).

Figure 4-5: a) Fracture energy (Gc) versus Young’s modulus (E) and b) work of extension (W) versus
swelling ratio (SW) comparison charts of ICE network hydrogels reported in this work (crosses) and
conventional hydrogels (diamonds), DN hydrogels (triangles), NC hydrogels (circles), rubbers
(squares) adapted from reference238.
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4.3.2

Immersion studies

ICE network hydrogels were immersed in simulated body fluid (SBF) for up to 144
hours. The gellan gum, gelatin, sodium, magnesium, potassium and calcium
concentrations and the pH of the SBF was measured at regular intervals in addition
to the swelling ratio of the hydrogel samples.
The concentrations of gellan gum and gelatin in the SBF reached a plateau value
after 48 hours of immersion (Supplementary Table 4-4). It is suggested that this is
release of free polymer chains (those unassociated with the gel network)180,303. The
relative amount of gellan gum leached was observed to increase in proportion to the
total polymer concentration to a maximum of 0.042 ± 0.009% (w/w) for 5.500%
(w/v) ICE network hydrogels (Figure 4-6a). The amount of gelatin leached as a
percentage of the gelatin used to prepare the hydrogels was observed to fluctuate
around an average value of 2 ± 2% (w/w), irrespective of the total polymer
concentration in the hydrogels (Figure 4-6b). This suggests that gellan gum and
gelatin release is small and not likely to have a large impact on gel properties.
The concentration of calcium in the SBF surrounding 2.75% (w/w) ICE network
hydrogels increased from 0.20 ± 0.05 μg.L-1 to 0.5 ± 0.3 μg.L-1 over the first 48
hours and did not change significantly afterwards (Figure 4-6c). The concentrations
of sodium, magnesium and potassium did not change significantly during the
immersion period (Error! Reference source not found.). Calcium ions are directly
involved in the cross-linking of gellan gum and it is possible that they were
exchanged with other ions such as sodium in the SBF resulting in weaker
networks120.
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The pH of SBF was observed to decrease by ~0.4 over the 144 hour study period
with the most dramatic change occurring within the first 24 hours for most polymer
concentrations (Figure 4-6d). The gellan gum possesses carboxylic acid functional
groups and the type of gelatin used to prepare the hydrogels is an acid hydrolysed
porcine gelatin so it is unsurprising that leaching of these materials lowered the pH
of solutions in which they were immersed.
All of the hydrogels de-swelled to some extent during the immersion study with the
majority of the de-swelling occurring within the first 24 hours. The hydrogels with
1.375% (w/v) polymer de-swelled from a swelling ratio of 75 ± 3 to 64 ± 4 over 144
hours, while all of the other hydrogels only changed marginally (Figure 4-6e). The
swelling ratio of ICE network hydrogels did not change significantly when immersed
in 0.1 M phosphate buffered saline (PBS) solutions at pHs between 4.5 and 8.6
(Figure 4-6f). Ordinarily, proteinaceous polymers such as gelatin change their
volume in response to being immersed in solution of different pH. For example, a
genipin cross-linked gelatin hydrogel (without gellan gum) de-swelled to 23% of its
original volume in a previously reported experiment117. This phenomenon occurs as a
result of ionisation of functional groups in these proteins at pHs above, below and at
the isoelectric point of the protein.
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Figure 4-6: a) The percentage of gellan gum leeched from hydrogels of different polymer
concentrations after 144 hours immersion in SBF, b) the percentage of gelatin leeched from hydrogels
of different polymer concentrations after 144 hours immersion in SBF, c) the concentration of calcium
in SBF containing a 2.75% (w/w) polymer hydrogel at different immersion intervals, d) The pH of
SBF containing a 2.75% (w/w) polymer hydrogel at different immersion intervals, e) the change in
swelling ratio of hydrogels of different polymer concentrations after 144 hours immersion in SBF, f)
the swelling ratio of 2.75% (w/w) polymer hydrogels after being immersed in 0.1 M PBS solutions for
24 h of different pHs (±SD).

4.3.3

Characteristics of swollen hydrogels

In the previous section, the composition was optimised and it was determined that 48
hours immersion in SBF was sufficient time for the hydrogels to reach an
equilibrium swelling state. ICE network hydrogels comprising of 36% (w/w) gellan
gum, 64% (w/w) gelatin, 2% (w/w) Ca2+ and 20% (w/w) genipin were prepared with
polymer concentrations between 1.375% (w/v) and 5.500% (w/v), and immersed in
SBF.
The compressive mechanical properties of ICE network hydrogels immersed in SBF
were compared to analogous as-prepared hydrogels, i.e. gels which had not been
immersed in SBF. The compressive failure stress and strain energy to failure
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increased with increasing polymer concentration between 1.375 and 2.750% (w/v)
but plateaued for higher polymer concentrations (Figure 4-7a-b). As-prepared
hydrogels possessed higher failure stresses and strain energies than fully swollen
hydrogels. The compressive secant moduli of both the as-prepared and fully swollen
hydrogels increased with increasing polymer concentration. However, the moduli of
immersed hydrogels were slightly lower than the non-immersed hydrogels (Figure
4-7c). The compressive strain to failure decreased with increasing polymer
concentration. Fully swollen hydrogels fractured at a lower strain than the
corresponding as-prepared hydrogels (Figure 4-7d).
Overall (and as expected), the magnitude of the mechanical properties of hydrogels
decreased as a result of swelling (Figure 4-7 and Supplementary Table 4-4). It is
suggested that the diminution of mechanical properties of immersed hydrogels may
be caused by loss of calcium ions from the hydrogels. This suggestion is supported
by a previous study where calcium cross-linked gellan gum hydrogels were shown to
be degraded via sodium-calcium ion exchange in vivo304.
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Figure 4-7: The polymer concentration affects the a) compressive failure stress (σc), b) compressive
strain to failure (Ɛc), c) compressive secant modulus (Ec), and d) strain energy to failure (U), of “as
prepared” (diamonds) and equilibrium swollen state (squares) hydrogels (± SD).

4.3.4

Recovery of hysteresis

Gellan gum-gelatin ICE network hydrogels comprising 2.75% (w/w) polymer were
compressed to either a constant stress of 150 kPa or a constant strain of 50% to
determine their ability to recover after a resting period in air (dry recovery) or
immersed in SBF (wet recovery). The energy dissipated (hysteresis) during the first
loading/unloading cycle to constant stress (150 kPa) or constant strain (50%) was 24
± 2 kJ.m-3 (Figure 4-8). The hysteresis reduced to 6 ± 2 kJ.m-3 when the gels were
immediately subjected to a second loading/unloading cycle (Figure 4-9). This
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reduction could be partially attributed to observed expelling of water during the
initial loading cycle. This could be indicative of a de-swelling effect and contributing
to the observed stiffening of the gels. Regardless of the resting time, the gels do not
improve the value of their hysteresis in the experiments to either constant strain
(Figure 4-9a), or constant stress (Figure 4-9b).

Figure 4-8: a) and b) Stress-strain curves for loading/unloading cycles 1 and 2 of typical ICE network
hydrogel (2.75% w/w) samples compressed to 50% after resting in air or immersed in SBF for 10 min
between cycles, respectively. c) and d) Stress-strain curves for loading/unloading cycles 1 and 2 of
typical ICE network hydrogel (2.75% w/w) samples compressed to 150 kPa after resting in air or
immersed in SBF for 10 min between cycles, respectively.

126

However, placing the gels in SBF results in a significant improvement in the
hysteresis (Figure 4-8). Allowing the gels to rest between cycles 1 and 2 for 5 hours
in SBF resulted in an increased hysteresis value (to constant strain) during the second
cycle of U2 = 20 ± 4 kJ.m-3, which is 82 ± 7% of the hysteresis of the first cycle
(Figure 4-9a). It is likely that the re-swelling of the gels is responsible of the
observed improved recovery in hysteresis. Similar results were obtained for gels
subjected to loading/unloading cycles to constant stress (Figure 4-9b). Resting the
gels between cycles 1 and 2 for 4 hours in SBF resulted in U2 = 23.4 ± 0.8 kJ.m-3,
which is equivalent to 95 ± 2% recovery of the hysteresis value of the first cycle.
Furthermore, our hydrogels were subjected to 5 cycles in succession each with 10
min resting in SBF between cycles. The hysteresis value decreased between cycles 1
and 2, but remained constant for subsequent cycles 3-5 (≈ 80% of the hysteresis
value of the first cycle). This behaviour combined with the observation that the reswollen gels regain their initial volume (but not swell beyond that volume) appears to
suggest that our gels might not be permanently damaged by the first
loading/unloading cycle as reported for some microgel reinforced gels253.
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Figure 4-9: a) Hysteresis of the second loading/unloading cycle of a typical ICE network hydrogel
(2.75% w/w) samples compressed to 50% of strain after resting in air (diamonds) or immersed in SBF
for 10 min (squares) after the initial loading/unloading cycle. b) Hysteresis of the second
loading/unloading cycle of a typical ICE network hydrogel (2.75% w/w) samples compressed to 150
kPa of stress after resting in air (diamonds) or immersed in SBF for 10 min (squares) after the initial
loading/unloading cycle.

4.4

Conclusions

This paper describes the preparation and characterization of a robust biopolymer
based ionic-covalent entanglement network hydrogels from gellan gum and gelatin.
The optimal concentrations of gellan gum, Ca2+, gelatin and genipin were identified
and the resulting hydrogels were demonstrated to be homogenous. The compressive
fracture stress and work of extension values of the optimized hydrogels were 1.1 ±
0.2 MPa (swelling ratio 37.4 ± 0.6) and 230 ± 40 kJ.m-3 (swelling ratio 19 ± 1),
respectively. The behaviour of the hydrogels when immersed in simulated body
fluid was investigated and it was observed that calcium was leached from the
hydrogels over time. It was suggested that the observed reduction in the magnitude
of the mechanical properties for swollen hydrogel could be attributed to the observed
loss of the calcium cross-linker.
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The ICE network hydrogels were able to recover to a significant proportion of their
hysteresis when rested in simulated body fluid (37 °C) for more than 10 minutes
between compression cycles 1 and 2. We showed that the hysteresis recovery was 95
± 2% under cyclic compression to a constant stress and 82 ± 7 under cyclic
compression to a constant strain. This paper contributes to the development and
understanding of interpenetrating polymer network hydrogels with (reversible and
sacrificial) ionic cross-linkers.
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4.5

Supporting information

4.5.1

Mechanical Characterisation

Supplementary Table 4-1: The compressive mechanical properties of gellan gum-gelatin hydrogels
possessing various molar network ratios (± standard deviation). Hydrogels were prepared with the
same concentrations of calcium and genipin cross-linkers but varying ratios of gellan gum and gelatin.

Gelatin / (gelatin + gellan gum)

σc

εc

Ec

U

(%)

(MPa)

(%)

(kPa)

(kJ.m-3)

56 ± 6

40 ± 5

33

0.27 ± 0.06 76 ± 2

50

0.6 ± 0.2

81 ± 3

56 ± 5

70 ± 20

56

0.8 ± 0.2

85 ± 2

60 ± 20

100 ± 10

60

0.9 ± 0.2

85 ± 2

79 ± 9

110 ± 20

64

1.1 ± 0.2

85 ± 1 120 ± 20 150 ± 20

69

0.8 ± 0.3

81 ± 4 180 ± 20 130 ± 40

71

0.5 ± 0.1

74 ± 4 180 ± 20

90 ± 20

0.25 ± 0.04 64 ± 2 260 ± 40

50 ± 20

80
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Supplementary Figure 4-1: The polymer network ratio affects the a) maximum compressive stress, b)
secant modulus, c) maximum compressive strain, and d) strain energy to failure (± SD).
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Supplementary Table 4-2: The compressive mechanical properties of gellan gum-gelatin hydrogels
possessing various calcium concentrations (± SD). Hydrogels were prepared with the same
concentrations of gellan gum and gelatin polymers and genipin cross-linker but concentrations of
calcium.

[Ca2+]

σc

εc

Ec

U

% (w/w)

(MPa)

(%)

(kPa)

(kJ.m-3)

0.0

0.30 ± 0.08 72 ± 4 120 ± 20

50 ± 10

0.4

0.5 ± 0.1

77 ± 3 160 ± 10

0.8

0.6 ± 0.2

82 ± 2 130 ± 10 100 ± 20

2

1.1 ± 0.2

85 ± 1 120 ± 20 150 ± 20

4

0.9 ± 0.2

82 ± 2 140 ± 10 130 ± 20

8

0.5 ± 0.1

69 ± 4 290 ± 30 100 ± 20

20

0.29 ± 0.01 64 ± 1 350 ± 20

132

80 ± 10

72 ± 4

Supplementary Figure 4-2: The concentration of calcium cross-linker affects the a) maximum
compressive stress, b) secant modulus, c) maximum compressive strain, and d) strain energy to failure
(± SD).
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Supplementary Table 4-3: The compressive mechanical properties of gellan gum-gelatin hydrogels
with genipin concentrations (± SD). Hydrogels were prepared with the same concentrations of gellan
gum and gelatin polymers and calcium cross-linker but concentrations of genipin.

[Genipin]

σc

εc

Ec

U

%(w/w)

(MPa)

(%)

(kPa)

(kJ.m-3)

0
4
8

0.19 ± 0.04 57 ± 3 190 ± 10
0.5 ± 0.1

74 ± 4 150 ± 10

38 ± 7
80 ± 20

0.64 ± 0.09 78 ± 2 150 ± 20 100 ± 10

12

0.7 ± 0.2

80 ± 3 120 ± 20 100 ± 30

16

1.0 ± 0.2

84 ± 2 100 ± 20 130 ± 20

20

1.1 ± 0.2

85 ± 1 120 ± 20 150 ± 20

24

1.1 ± 0.2

85 ± 1 110 ± 20 140 ± 20

28

1.0 ± 0.1

86 ± 2 100 ± 10 140 ± 20
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Supplementary Figure 4-3: The concentration of genipin cross-linker affects the a) maximum
compressive stress, b) secant modulus, c) maximum compressive strain, and d) strain energy to failure
(± SD).
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4.5.2

Immersion studies

Supplementary Table 4-4: Gellan gum and gelatin concentration and pH of simulated body fluid and
the corresponding swelling ratio of hydrogels with different polymer concentrations with respect to
immersion time.

Gelatin
Gellan gum

Swelling
leeched

Polymer Immersion

pH

leeched (%)

ratio
(%)

%(w/v)

time (h)
AVG

SD

AVG

SD

AVG

SD

AVG

SD

0.0000

0.0000

0.0

0.0

7.46

0.00

75

3

3

0.0

0.1

7.54

0.01

70

2

6

1

1

7.55

0.02

68

4

12

0.8

0.9

7.49

0.03

66

3

2

2

7.55

0.02

66

3

2

2

7.54

0.02

65

4

2

1

7.50

0.03

65

3

96

2

1

7.48

0.02

65

3

120

3

3

7.44

0.03

64

2

5

4

7.46

0.03

64

4

0

24

0.002

0.001

1.375
48
72

144

0.0024

0.0032

0.0007

0.0006

136

Gelatin
Gellan gum

Swelling
leeched

Polymer Immersion

pH

leeched (%)

ratio
(%)

%(w/v)

time (h)
AVG

SD

AVG

SD

AVG

SD

AVG

SD

0.0000

0.0000

0.0

0.0

7.39

0.00

53

2

3

0.5

0.1

7.12

0.02

53

2

6

1.0

0.3

7.10

0.02

53

2

12

1.6

0.3

7.08

0.02

53

2

2.5

0.3

7.12

0.02

52

2

3.3

0.4

7.04

0.02

51

2

3.6

0.7

7.04

0.04

52

2

96

3.3

0.5

6.99

0.01

51

2

120

3.3

0.4

6.96

0.01

52

2

3.6

0.5

7.00

0.03

51

2

0

24

0.0026

0.0009

2.062
48
72

144

0.002

0.0017

0.001

0.0003
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Gelatin
Gellan gum

Swelling
leeched

Polymer Immersion

pH

leeched (%)

ratio
(%)

%(w/v)

time (h)
AVG

SD

AVG

SD

AVG

SD

AVG

SD

0.0000

0.0000

0.0

0.0

7.34

0.00

40.9

0.6

3

0.5

0.2

7.10

0.02

40.5

0.6

6

1.6

0.7

7.09

0.02

40.7

0.6

12

3.4

0.9

7.04

0.02

40.1

0.6

5.9

0.8

7.02

0.02

39.9

0.6

9

2

6.95

0.02

40.0

0.6

8

2

6.89

0.02

39.7

0.5

96

8

2

6.88

0.02

39.7

0.6

120

6

1

7.00

0.03

39.9

0.7

7.2

0.9

6.90

0.03

39.5

0.5

0

24

0.0018

0.0009

2.750
48
72

144

0.002

0.0022

0.001

0.0003
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Gelatin
Gellan gum

Swelling
leeched

Polymer Immersion

pH

leeched (%)

ratio
(%)

%(w/v)

time (h)
AVG

SD

AVG

SD

AVG

SD

AVG

SD

0.0000

0.0000

0.0

0.0

7.31

0.00

31.4

0.7

3

0.1

0.1

7.06

0.02

31.2

0.8

6

1.0

0.9

7.05

0.02

31.1

0.7

12

2.3

0.9

6.99

0.02

31.0

0.7

5

2

6.91

0.02

30.9

0.7

7

2

6.86

0.02

30.9

0.7

6

2

6.83

0.02

30.7

0.7

96

5

1

6.77

0.02

30.9

0.7

120

4.6

0.8

6.79

0.01

30.8

0.7

5

2

6.78

0.02

30.7

0.7

0

24

0.0029

0.0007

3.438
48
72

144

0.0023

0.0026

0.0008

0.0006
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Gelatin
Gellan gum

Swelling
leeched

Polymer Immersion

pH

leeched (%)

ratio
(%)

%(w/v)

time (h)
AVG

SD

AVG

SD

AVG

SD

AVG

SD

0.0000

0.0000

0.0

0.0

7.50

0.00

26.1

0.7

3

0.1

0.2

7.31

0.02

25.9

0.6

6

0.6

0.6

7.26

0.02

25.8

0.6

12

1.0

0.7

7.19

0.02

25.7

0.6

1.4

0.8

7.15

0.03

25.6

0.6

1.5

0.6

7.12

0.03

25.5

0.6

1.5

0.7

7.07

0.03

25.6

0.6

96

1.5

0.4

7.07

0.02

25.5

0.6

120

1.5

0.7

7.07

0.02

25.5

0.6

1.9

0.8

7.12

0.03

25.5

0.6

0

24

0.0032

0.0008

4.125
48
72

144

0.0032

0.004

0.0009

0.002
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Gelatin
Gellan gum

Swelling
leeched

Polymer Immersion

pH

leeched (%)

ratio
(%)

%(w/v)

time (h)
AVG

SD

AVG

SD

AVG

SD

AVG

SD

0.0000

0.0000

0.0

0.0

7.44

0.00

21.4

0.7

3

0.0

0.0

7.35

0.02

21.2

0.6

6

0.1

0.0

7.30

0.02

21.2

0.7

12

0.4

0.2

7.26

0.03

21.1

0.7

0.9

0.4

7.21

0.02

21.1

0.7

0.9

0.4

7.16

0.01

21.0

0.7

0.9

0.5

7.15

0.02

21.0

0.7

96

0.7

0.3

7.16

0.02

21.0

0.6

120

0.6

0.2

7.20

0.04

21.0

0.6

0.7

0.2

7.31

0.04

21.0

0.7

0

24

0.0033

0.0007

4.812
48
72

144

0.0025

0.0036

0.0004

0.0009
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Gelatin
Gellan gum

Swelling
leeched

Polymer Immersion

pH

leeched (%)

ratio
(%)

%(w/v)

time (h)
AVG

SD

AVG

SD

AVG

SD

AVG

SD

0.0000

0.0000

0.0

0.0

7.34

0.00

19

1

3

0.4

0.1

7.32

0.01

19

1

6

1.4

0.4

7.31

0.02

19

1

12

2.4

0.6

7.29

0.03

19

1

3

1

7.13

0.03

19

1

3

1

7.14

0.03

19

1

3

1

7.12

0.04

19

1

96

2.3

0.6

7.17

0.04

19

1

120

2.0

0.6

7.15

0.04

19

1

2.3

0.7

7.17

0.03
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Supplementary Figure 4-4: Change in concentration of sodium, magnesium, potassium and calcium
ions in SBF with a 2.75% (w/w) polymer hydrogel immersed in them for different periods of time.
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Abstract
Microscopic hydrogel spheres can be used to improve the mechanical properties of
conventional hydrogels. We prepared ionic-covalent entanglement (ICE) hydrogel
microspheres of calcium cross-linked gellan gum and genipin cross-linked gelatin
using a water-in-oil emulsion based processing technique. The method was optimised
to produce microspheres with number average diameter 4 ± 1 µm. These ICE
microspheres were used to reinforce gelatin hydrogels and improve their
compressive mechanical properties. The strongest microsphere reinforced hydrogels
possessed a compressive mechanical stress at failure of 0.50 ± 0.1 MPa and a
compressive secant modulus of 0.18 ± 0.02 MPa.
5.1

Introduction

Tissue engineering technologies may one day provide a plentiful supply of highly
compatible laboratory grown tissue and organs for implantation2. The tissue scaffold,
i.e. the material that reinforces the component’s structure and holds the cells in place
during maturation, is a critical component of all in vitro tissue engineering
strategies2. For engineering of soft tissues, hydrogel materials are the most
appropriate scaffold materials because they have similar mechanical properties and
chemical composition to natural tissues37,139.
Hydrogels are a class of polymeric materials whose composition comprises a small
fraction of hydrophilic polymer network with water or aqueous solution as the major
fraction36. Hydrogels make excellent materials for engineered tissue scaffolds
because they resemble the composition of natural extracellular matrix and possess
mechanical properties similar to most soft tissue10. Hydrogels are also excellent
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materials to use for drug delivery because they can easily absorb, retain and release
bioactive molecules284.
Many hydrogels have very weak mechanical properties despite having excellent
biocompatibility and utility as tissue scaffolds. Certain tissue types, such as cartilage,
require scaffolds which are strong, highly durable and resistant to fracture. Recently,
topological hydrogels239, tetra-PEG hydrogels240, double network (DN) hydrogels241–
244,290,291

, ionic covalent entanglement (ICE) network hydrogels68,69,245,246,293 have

been reported which are significantly stronger and tougher than conventional
hydrogels. However, some of these strategies only work with very specific polymers
and reagents and/or have very constricting methods for their preparation which
greatly limits the options for polymer choice and fabrication approach. For example,
DN hydrogels must be prepared in a two-step method where one network is swollen
in a monomer solution of the secondary network, a preparation method which is not
amenable to printing or extrusion242. Reinforcement of regular hydrogels with
microgel particles is an alternative method for improving hydrogel properties which
is in many ways more versatile than the abovementioned methods247.
Hydrogel microspheres can be used to reinforce hydrogels where they act as
multifunctional cross-linking nodes254,255. In a microgel reinforced hydrogel (MRhydrogel), the microspheres inhibit the formation of micro-cracks and voids in the
bulk hydrogel which are responsible for the rapid and catastrophic fracturing
observed in unreinforced hydrogels254. MR-hydrogels have also demonstrated
effectiveness at presenting biological cues in a controlled fashion when used as a
cartilage scaffold256. Previously it was shown that double network hydrogel
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microspheres improved the mechanical properties of poly(acrylamide) hydrogels and
we propose to use ICE hydrogel microspheres to strengthen gelatin hydrogels in a
similar way 247,249,253. ICE hydrogels are an interpenetrating network of an ionotropic
polymer and a chemically cross-linkable polymer which possess above average
strength and toughness68,69,245,246.
A variety of methods have been reported for making hydrogel microspheres of
gelatin and other polymers which have typically been used for drug delivery and
controlled drug release applications171,259,297,305. Of the many available options,
emulsion based strategies offer a fast and scalable method for the production of
nano- and micro- sized droplets which can be set as spheres upon cooling below the
gel transition temperature306. Basic water in oil emulsions are very easy to prepare
and require only simple shearing that can, and often is, achieved with bench-top
stirrers. However, these basic emulsions will prepare droplets/spheres between 10
µm and 1000 µm with a large size distribution307. The finest emulsions are prepared
under high shear and highly controlled shear in the presence of an appropriate
emulgent where almost monodisperse droplets form as a result of Rayleigh
instability307. Many factors affect the ability to emulsify a solution (for example, of
gellan gum and gelatin), including the choice of emulgents, emulgent concentration,
and the choice of oil307.
The microspheres presented in this manuscript are comprised of an ICE hydrogel
prepared from calcium cross-linked gellan gum and genipin cross-linked gelatin.
Gellan gum is a polysaccharide biopolymer produced from the bacteria
Pseudomonas elodea that forms a firm gel upon cooling to below its gel transition
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temperature (~45°C)51,175,176. The strength of gellan gum hydrogels is significantly
affected by the presence of cross-linking cations and in particular, calcium cations
produce strong thermally irreversible hydrogels that enable microspheres to be
produced from emulsions by thermal modulation178,182. Gelatin is a proteinaceous
biopolymer produced from the controlled hydrolysis of collagen54. Ordinarily, gelatin
hydrogels swell extensively; rapidly dissolve above the gel transition temperature
(~29°C), and lose their strength and rigidity rapidly54,158,159. However, covalently
cross-linking the gelatin with genipin (the algycone of geniposide, an iridoid
glycoside that is the major component of the fruit of the gardenia plant, Gardenia
jasmindides Ellis163) remedies these limitations117,162. Genipin forms chemical crosslinks mainly between the primary amino groups of either the ε-amino groups of the
lysine residues in gelatin and it is this reaction that is responsible for both the
formation of the ICE network but also the coupling of the microsphere phases to the
bulk hydrogel phase in MR-hydrogels167.
In this paper, we present a simple method for the preparation of gellan gum-gelatin
ICE hydrogel microspheres. The optimal emulgent hydrophile-lipophile balance
(HLB) was identified, and the effect of emulgent concentration was explored. A
variety of different oils were examined for their effectiveness at producing the
microsphere-forming emulsions. The size of the resulting microspheres was
characterised and their ability to reinforce gelatin hydrogels was evaluated.
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5.2
5.2.1

Experiment
Materials and equipment

Hydrogels were prepared from acid hydrolysed porcine gelatin (Bloom number of
300, molecular weight of 87,500 Da, Sigma Aldrich, USA) and low acyl gellan gum
(CP Kelco, Singapore) using deionised water (DI) which had been purified using a
combination ion-exchange/reverse osmosis filtration system (Millipore, USA) to a
resistivity of 18 MΩcm. The hydrogels were cross-linked using solutions of genipin
(Challenge Bioproducts, Taiwan) and CaCl2 (Sigma Aldrich, USA). Water-in-oil
(w/o) emulsions were formed using canola oil (Crisco, USA), hydraulic oil
(Ultramax 46, Valvoline), machine oil (X68, Caltex), 3-in-1 oil (3-in-1, USA) and
paraffin oil (Recochem, Australia) with non-ionic surfactants Tween 80 (Sigma
Aldrich, USA) and Span 80 (Merck, Australia). Solvents used for washing residual
oils and surfactants from hydrogel microspheres included toluene (BDH, Australia),
petroleum spirit (BDH, Australia), dichloromethane (Ajax Finechem, Australia),
acetone (Ajax Finechem, Australia) and ethyl acetate (BDH, Australia).
5.2.2

Microsphere fabrication

ICE hydrogel solutions comprising 1% (w/v) gellan gum, 1.75% (w/v) gelatin and
2% (w/w) Ca2+ were prepared by dissolving the gellan gum and gelatin in DI water at
80°C with gentle stirring on a combined magnetic stirrer/hot plate (CB162, Stuart,
UK) for 30 minutes before 1 M CaCl2 solution was added. These ICE hydrogels
possessed compressive failure stress of 1.1 ± 0.2 MPa, strain to failure of 85 ± 1%
and secant modulus of 120 ± 20 KPa. Oil/emulgent mixtures were prepared
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separately at 60°C. Unless otherwise stated, the oil/emulgent mixtures were 0.1%
(w/w) Tween 80 and 0.9% (w/w) Span 80 in paraffin oil.
Emulsions, unless otherwise stated, were prepared using a tissue homogeniser (HG15D Wisemix, Daihan Scientific, Korea) with dispersing tool (HT1018, Wisemix,
Daihan Scientific, Korea) which was pre-warmed to 60°C by immersing the tool in
hot water. 200 mL of hydrogel solution was added slowly to 300 mL of oil-emulgent
mixture whilst stirring at 2,000 rpm in a 600 mL low-form glass beaker (Crown,
Australia). After the solutions were combined, the speed was increased to 7,000 rpm
and maintained for 5 minutes (Figure 5-1 i). The emulsion was kept warm
throughout the homogenising using a hotplate (CB162, Stuart, UK).

Figure 5-1: Procedure for the fabrication of ICE hydrogel microspheres using emulsification to create
micro-sized droplets of hydrogel solution and thermal modulation to set the droplets into firm
hydrogel microspheres.
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The emulsion was gelled into a microsphere suspension immediately after stirring by
pouring it into an ice-cold, 1L glass bottle (Schott, Germany), and then plunging the
bottle into a bucket of ice for approximately 15 minutes (Figure 5-1 ii). The oil and
emulgents were removed from the microspheres by washing with two 500 mL
portions of petroleum spirits, and one 450 mL portion of petroleum spirits with 50
mL ethyl acetate added (Figure 5-1 iii). The microspheres were then freeze dried
completely (Alpha LD plus, Christ, Germany) (Figure 5-1 iv).
5.2.3

MR-hydrogel preparation

MR-hydrogels were prepared by combining freeze-dried microspheres with a
solution of gelatin at 50°C and stirring gently for 10 minutes to allow the
microspheres to swell and rehydrate (Figure 5-2 i). Subsequently, the solution was
cross-linked by addition of genipin solution (20.3% w/w in 60% ethanol) to a
concentration of 200 mg genipin per gram gelatin and stirring for a further three
minutes (Figure 5-2 ii). The gel solution was then poured into glass Petri dish moulds
(60 mm diameter x 15 mm height, Schott, Australia) and left to cure, covered, for 24
hours at 21°C. Silanisation of the Petri dishes using Coatasil (Ajax Finechem,
Australia) glass treatment solution prior to casting facilitated easy removal of the
cured hydrogels from the dishes. The swelling ratio (SW) of hydrogels were
calculated as the mass of the swollen hydrogel (ms) divided by the mass of the dried
hydrogel (md).

.

(1)
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Figure 5-2: Procedure for preparation of MR-hydrogels.

5.2.4

Rheology

The viscosities of the gel solution and various oils were analysed using a rheometer
(Physica MCR-301, Anton Paar, Australia) with temperature controlled stage
(AWC100, Julabo, Germany), a 50 mm diameter and 1° cone and plate tool (CP50-1,
Anton Paar, Australia), with a gap length of 0.097 mm. The viscosity was measured
over a range of temperatures spanning from 80°C down to 4°C by applying a
rotational shear of 100.s-1 while gradually lowering the temperature at a rate of 5°C.min-1.
5.2.5

Size analysis

An optical microscope (DM6000, Leica, Germany) was used to take micrographs of
the microspheres. Leica Application Suite (Leica, Germany) was used to measure the
size and size distribution of the microspheres. Samples prepared for optical
microscopy were prepared by suspending the microspheres in DI water and dropping
onto glass microscopy slides. Freeze dried microspheres were rehydrated for 10
minutes in DI water prior to analysis.
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5.2.6

Mechanical analysis

The mechanical properties of the hydrogels were examined in compression using a
universal analyser (EZ-S, Shimadzu, Japan). Samples were cut from slabs of
hydrogel into rectangular prisms 10 mm x 10 mm x 7 mm, and subsequently
compressed at a rate of 2 mm.min-1 at 21˚C. The resulting stress-strain data was used
to determine the compressive failure strain (εc), compressive secant modulus over
20%-30% strain (Ec), compressive failure stress (σc) and compressive strain energy to
failure (U).
5.3
5.3.1

Results
Optimisation of microsphere production

For the first time, microspheres of ICE hydrogels were prepared using emulsion
based processing and thermal modulation of the gel solution (Figure 5-1). It was
found that ICE hydrogel microspheres could be prepared in approximately 1-2 hours
and that it could be performed easily on a 200 mL scale which is much quicker and
larger scale than all previously reported DN microspheres which took over 8 hours to
prepare a significantly smaller quantity247,249,253. The optimal process for preparing
hydrogel microspheres was determined by independently examining the effects of i)
the type and viscosity of oil; ii) the emulgent HLB value; and iii) the emulgent
concentration.
The hydrophile-lipophile balance (HLB) of the emulgent used to prepare emulsions
was observed to have an effect on the type of emulsion formed, its stability, and the
ultimate quality of the microspheres produced. Emulgents with HLB values between
4.3 and 15 were used to prepare emulsions of paraffin oil and gel solution. The
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emulsions were assessed qualitatively by inspecting micrographs of the emulsions
which had be set by dropping the temperature immediately after shearing ceased
(Figure 5-3). The stability of the emulsions were also assessed qualitatively by
comparing micrographs of the same emulsion taken immediately after shearing
ceased and 10 minutes afterwards. Emulsion prepared with emulgent HLB values
between 15.0 and 11.8 formed oil-in-water (o/w) type emulsions. These emulsions
created porous hydrogel sponges with droplets of oil trapped in the pores after being
cooling. Emulsions prepared with HLB values of 10.7 and 9.6 produced oil-in-waterin-oil (o/w/o) double emulsions initially, which would transform into single o/w
emulsions gradually over 10 minutes. Emulsions prepared with emulgent HLB
values of 8.6 and 7.5 produced unstable water-in-oil (w/o) emulsions that would
coalesce and agglomerate noticeably over 10 minutes. The best quality hydrogel
microspheres and most stable w/o emulsions were prepared using emulgents with
HLB values between 4.5 and 6.4.

Figure 5-3: Micrographs of emulsions prepared with different HLB values. a) An o/w emulsion
formed with emulgent HLB value of 13.9. b) An o/w/o emulsion formed with emulgent HLB value of
9.6. c) A w/o emulsion formed with emulgent HLB value of 6.4.

154

The concentration of emulgent affected the stability of the emulsion and the size of
microspheres prepared from the emulsion. Emulsions were prepared using different
concentrations of emulgent (HLB value = 5.4) ranging from 0.1% (w/w) to 8%
(w/w). Emulsions formed with 0.1% emulgent were not stable and coalesced back
into two separate layers before the gel solution set. When 0.5% or more emulgent
was used, stable emulsions were formed for long enough to cool the gel solution to
below the gel transition point and form microspheres. With increasing emulgent
concentration, the average microsphere diameter decreased as did the size
distribution of the microsphere (Figure 5-4). When more than 4% emulgent was used
the microspheres produced were very small (<10 µm) and highly stabilised in
paraffin oil by the presence of a large amount of surfactant; this made it difficult to
separate the microspheres from the oil after setting. In general, the time it took for
microspheres to settle out of suspension increased in proportion to the concentration
of emulgent used and was between 5 minutes and 2 hours for all concentrations
tested excepting those made with 8% (w/w) emulgent which took one week to settle.
An optimal range of emulgent concentration was identified as 1 – 2% (w/w), where
the average diameter and size distribution of microspheres are minimised and the
ease of processing them was maximised.
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Figure 5-4: a) The number average diameter of microspheres prepared from emulsions with different
concentration of emulgent. Error bars indicate the standard distribution of microsphere diameters
which also decrease with increasing emulgent concentration. b) Photograph of 10 mL of microspheres
taken approximately 5 minutes after resuspending in 30 mL of petroleum spirit. Orange lines on the
photo indicate the extent of settling at this point in time – the settling time increases with increasing
emulgent used to prepared the microspheres. The concentration of emulgent used to prepare the
microspheres increases from left to right in sequence: 0.5%, 1.0%, 2.0%, 4.0%, 8.0%

Rheological measurements of ICE hydrogel solution over the temperature range of
80 - 10°C indicated that the gel transition temperature of the ICE network was
approximately 45°C (Figure 5-5a). The viscosities of five different oils were also
examined over the same temperature range and found to range from 11 to 42 mPa.s
at a shear rate of 100 s-1 at 45°C (Figure 5-5b). These five different oils were then
used to prepare ICE microspheres under identical conditions (1% emulgent with
HLB value of 5.4) and it was observed that the type of oil affected the size of the
microspheres produced which ranged from 14 – 60 µm and with varying size
distributions (Table 5-1). A correlation between the size distribution (expressed as
the relative standard deviation of the diameter measurements) of the microspheres
and the viscosity of the oil used to prepare them was observed (Figure 5-5b) – in
general, it was observed that higher viscosity oils, produced microspheres with
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smaller size distributions. This observation is explicable as the effect caused
Rayleigh instability which causes droplets in an emulsion to fragment towards a size
distribution that is dependent on the relative viscosities of the dispersed and
continuous phases307. Despite the large size distribution attained through using
paraffin oil (the lowest viscosity oil), it was selected for continued use throughout
our experiments because it was the easiest oil to extricate fully from the
microspheres after fabrication.

Table 5-1: Tabulated viscosity (@ 100s-1, 45°C) different oils used to prepare ICE microspheres and
their corresponding microsphere diameters.

Viscosity @ 100s-1,

Number average

45°C (mPa.s)

diameter (µm)

Paraffin oil

11

60 ± 50

3-in-1 oil

15

14 ± 9

Canola oil

28

14 ± 8

Hydraulic oil

30

50 ± 20

Machine oil

42

25 ± 8
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Figure 5-5: a) Viscosity at 100 s-1 versus temperature during cooling from 80 – 10°C of ICE hydrogel
solution, b) viscosity at 100 s-1 versus temperature of different oils c) Microsphere size distribution
expressed as relative standard deviation versus oil viscosity (at 100 s-1, 45 °C). Solid line is a guide to
the reader’s eye.

158

5.3.2

Mechanical reinforcement of hydrogels

Gellan gum-gelatin ICE hydrogel microspheres were used to reinforce gelatin
hydrogels (Figure 5-6). These hydrogels were prepared with a total polymer
concentration of 6% (w/w) (swelling ratio of 17.7) made up of gelatin and freezedried ICE microspheres in different proportions. The freeze-dried microspheres were
observed to hydrate and swell almost immediately upon mixing with the polymer
solution to a final size of 4 ± 1 µm (Figure 5-6).

Figure 5-6: a) Micrograph of gelatin hydrogel which has been reinforced by replacing 40% of the
polymer with freeze-dried microspheres; b) size distribution of microspheres in MR-hydrogels.
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Hydrogels comprised entirely of genipin cross-linked gelatin (no added
microspheres) were relatively soft and ductile (Figure 5-7) and possessed
compressive failure stress of 0.41 ± 0.09 MPa, compressive strain to failure of 69 ±
2%, compressive secant modulus of 0.074 ± 0.008 MPa and compressive strain
energy to failure of 39 ± 7 kJ.m-3. The MR-hydrogels exhibited a maximum in
mechanical properties at a microsphere fraction of 40% (Figure 5-8). In comparison
to gelatin only hydrogels, the MR-hydrogels were stiffened (increase in Ec to 0.18 ±
0.02 MPa) without losing their ductility and had a resultant increase in compressive
strain energy to failure to 70 ± 10 kJ.m-3.
In comparison to DN MR-hydrogels presented in recent literature our hydrogels
appear weaker. Jian Ping Gong’s PAMPS/PAAm microgel reinforced PAAm
hydrogels possessed tensile fracture stresses of 2.46 MPa and Young’s modulus of
0.22 MPa, however, these hydrogels had lower swelling ratio 6.7253. The scale that
our ICE MR-hydrogels were prepared was also significantly larger (~15 mL pieces
of hydrogel) than the DN MR-hydrogels (~1 mL)253.
Increasing the microsphere fraction above 40% led to a reduction in the values of the
mechanical properties (Figure 5-8). For example, increasing the fraction from 40% to
60% resulted in a significant reduction in stress at failure (from 0.5 MPa down to 0.1
MPa). When gels were composed entirely of microspheres (100%), a self-supporting
but weak gel which behaved like a semi-viscous fluid with an undetermined yield
stress was apparent. This indicates that ratio of microspheres to bulk phase polymer
is an important determinant of the mechanical performance of these hydrogels.
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Figure 5-7: Stress versus strain curves for gelatin hydrogel reinforced with 40% (w/w) ICE hydrogel
microspheres (unbroken line), and 6% (w/v) gelatin hydrogel (dashed line).

The mechanical behaviour of our gels is consistent with MR-hydrogels being a twophase composite consisting of gelatin network and microgels253. It has been
previously proposed that the stiffening (increase in Ec) is a result from topologically
constrained chain entanglements of the gelatin matrix and the ICE microgels253.
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Figure 5-8: Compressive mechanical properties of 6% gelatin hydrogels where 0% to 80% of the
polymer is replaced by gellan gum-gelatin ICE hydrogel microspheres.

5.4

Conclusion

The preparation of gellan gum-gelatin, ICE hydrogel microspheres using the oil-inwater emulsion method was optimised. It was determined that the optimal mixture of
emulgents was 1 part Tween 80 to 9 parts Span 80 (by weight) which produced an
emulgent mixture with a HLB value of 5.4. It was observed that the emulgent
concentration was inversely proportionate to microsphere number average diameter,
however, the optimal concentration of emulgent was considered to be 1% (w/w)
because it provided a good compromise between small microsphere diameter and
ease of process-ability. A variety of different oils were also successfully used to
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prepare the microspheres and a correlation between oil viscosity and size distribution
was observed.
Microspheres were used to reinforce gelatin hydrogels where it was demonstrated
that an optimal proportion of microspheres was 40% (w/w) of the total polymer in
the hydrogel. These produced hydrogels which exhibited reinforcement compared to
the gelatin matrix.
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GENERAL CONCLUSIONS
Tissue engineering is a rapidly developing field that will one day address the supply
shortage of replacement tissue and organs for the world’s growing population.
Hydrogel materials have been studied extensively over the past three decades as
candidate materials for soft tissue scaffolds which form the fundamental support
structure for engineered soft tissues. One of the greatest challenges faced by tissue
engineers to date is the identification of suitable hydrogel-forming polymers that
meet the extensive list of performance criteria including, but not limited to;
mechanical robustness and compatibility; non-toxicity and biocompatibility of the
polymers and reagents required to process them; degradability or non-degradability
as the situation requires; and process-ability of the materials to form complex
scaffold shapes and structures. This thesis presents gelatin and gellan gum based
hydrogel materials and demonstrates their mechanical, degradation and physical
properties.
Chapter 2 reported the development of a hydrogel material from genipin cross-linked
gelatin. It details the extent of cross-linking; swelling behaviour; degradation and
leeching profiles; rheological behaviour; mechanical properties and ability of the
hydrogels to be vascularised. It was revealed that hydrogels comprising between 2%
and 10% (w/v) gelatin with up to 20% (w/w) genipin would form self-supporting
hydrogels with highly tuneable mechanical, rheological and degradation properties.
The strongest gels possessed compressive mechanical performance similar to other
previously reported genipin and gluteraldehyde cross-linked gelatins160,161,260. It was
also demonstrated that the degradation rate could be adjusted most effectively
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through modulation of the genipin cross-linker concentration. This material was also
shown to have the potential to be vascularised through a modified chick CAM
experiment. In this experiment, it was observed that over several days, blood vessels
emerging from a chick embryo were attracted to PMA loaded hydrogels and intruded
into them. The research presented in Chapter 2 addresses Aim 1 of this thesis by
describing the preparation of a material which was able to be vascularised and had
tuneable mechanical, degradation and swelling properties. The presence of a
vasculature in a cell scaffold, like in natural tissue, enables nutrients and oxygen to
be delivered to cells throughout the component entirely thus overcoming limitations
of mass transfer. The material described in this chapter might potentially be used in
the future as a thick tissue scaffold for tissue engineering, however, it would be
necessary to confirm the material’s biocompatibility and degradability in vivo first.
Chapter 3 reported the purification and properties of low acyl gellan gum.
Commercially prepared low acyl gellan gum is an ionotropic hydrogel-forming
biopolymer which has potential as a material for soft tissue engineering and in
particular 3D extrusion printing of scaffolds. However, it is known that gellan gum
contains divalent cation contaminants as supplied which affect the hydration and gel
transition temperatures. A method was adopted from the one previously reported by
Doner and Landis279,281 to purify commercial gellan gum to be free from divalent
cation contaminants and prepare a sodium salt of the gellan gum. The purification
method successfully removed Ca2+ and Mg2+ cations with a 64 ± 6% yield of the
sodium salt gellan gum product. It was demonstrated that both the dissolution
temperature and the gel transition temperature could be lowered by purifying the
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commercial gellan gum to the sodium salt but that this process had a deleterious
effect on the mechanical properties of hydrogels prepared from these polymers.
Notwithstanding, the sodium salt gellan gum possess a dissolution temperature (at
1% w/v) of 39 ± 4°C and a gel transition temperature with calcium ions present of 37
± 2°C. The research presented in this Chapter (3) addresses Aim 2 of this thesis by
presenting a material that can be prepared and gelled at normal body temperature
(37°C) providing it with the potential to be combined with cells safely and produce a
cellular ink which could potentially be fabricated using extrusion or ink jet printing
into complex 3D structures and tissue scaffolds203.
Chapter 4 reports the preparation of a hybrid, ionic-covalent entanglement (ICE)
hydrogel comprised of calcium cross-linked gellan gum and genipin cross-linked
gelatin. This novel hydrogel type builds upon the toughening principals of double
network hydrogels and adds to them a self-recovering aspect which was
demonstrated in this work. It was shown that the proportions of the two network
polymers and their respective cross-linkers have a significant effect on the
compressive mechanical properties with the optimal hydrogels prepared possessing
high swelling ratios. The mechanical properties of the ICE hydrogels were shown to
be significantly better than hydrogels prepared of their constituent network polymers
combined. The effect of immersion of these hydrogels in SBF was investigated on
compressive mechanical properties; the leeching of calcium, genipin, gelatin and
gellan gum; and the degradation and swelling of the hydrogels. It was shown that
immersion of ICE hydrogels in SBF leeched calcium from the hydrogels and that the
mechanical performance of the hydrogels diminished but the hydrogels themselves
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were dimensionally stable (non-swelling) and they did not degrade otherwise over a
144 hour period. The ICE hydrogels possessed the ability to almost completely
recovery from a small compressive load if allowed to rest for 10 minutes in SBF. The
research presented in Chapter 4 addresses Aim 3 of this thesis by demonstrating the
preparation of a material which has a mechanical robustness greater than
conventional hydrogels. The mechanical stiffness of the ICE hydrogel was similar to
that of cartilage itself308,309, so the material might be potentially used as a temporary
cartilage tissue scaffold or for any other biomedical application where mechanical
robustness is desirable.
Chapter 5 reports a method for the preparation of ICE hydrogel microspheres of
gellan gum and gelatin. This method involved the setting of a water-in-oil emulsion
prepared using the non-ionic surfactants Tween 80 and Span 80. The optimal mixture
of emulgents was 1 part Tween 80 to 9 parts Span 80 (by weight) which produced an
emulgent mixture with a HLB value of 5.4 and total concentration of 1% (w/w)
which were effective at producing microspheres 4 ± 1 µm in diameter. The effect of
other emulgent HLB values were examined where it was found that HLB values
above 11.8 produce oil-in-water emulsions, and HLB values below 7.5 produced
water-in-oil emulsions of varying stability. The total concentrations of emulgent and
choice of oil was also examined and found to affect the microsphere diameter and
size distribution, respectively. It was then shown that microspheres could be used to
reinforce gelatin hydrogels with the optimal fraction of polymer present as
microspheres was 40% (w/w). However, it was shown that the ICE microspheres
could not be used to reinforce bulk ICE hydrogels. The research presented in Chapter
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5 addresses Aim 4 of this thesis as it demonstrates how hydrogel microspheres can
be prepared and incorporated into a hydrogel to improve the mechanical
performance. This material may also be a potential candidate material for cartilage
tissue scaffolds provided the materials recoverability could be shown. The
microsphere may also be a useful material for inclusion in ink formulation for 3D
printing as they impart thixotropic properties to hydrogel solutions – however, a
much more thorough study on this aspect would be required to confirm this.
This thesis has contributed to the field engineered soft tissue scaffolds by developing
new hydrogel materials which are highly versatile in terms of mechanical properties,
gelation behaviour and degradability. The new materials highlight the potential of
genipin cross-linked gelatin based materials to be used as vascularisable scaffold
materials, and for hybrid hydrogels of genipin cross-linked gelatin and calcium
cross-linked gellan gum to prepare stronger than normal hydrogels which can recover
from mechanical strains. Gellan gum was altered/purified to enhance its gelation
properties and make it further amenable to computer aided tissue engineering of soft
tissue scaffolds. It was also demonstrated that ICE hydrogel microspheres of gelatin
and gellan gum can be fabricated and incorporated into gelatin hydrogels to improve
the mechanical performance. In summation, genipin cross-linked gelatin and calcium
cross-linked gellan gum were shown to be versatile hydrogel-forming polymers with
tremendous potential for use as engineered soft tissue scaffold materials.
Now that the mechanical properties of these materials has been thoroughly explored,
future work with these materials should involve in vivo studies that could confirm the
biocompatibility of the materials with cells and animal models as well as gauge the
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degradability in vivo. The printability of purified gellan gum based materials should
be explored thoroughly as this may have significance to the combined extrusion
printing of cells and hydrogels which is an important step towards computer aided
tissue engineering and whole organ tissue engineering objectives. The ICE hydrogels
materials showed excellent mechanical properties and recoverability which are
important features with respect to their potential to be used for cartilage tissue
scaffolds, however, it may be possible to further improve the mechanical
performance of these hydrogels by making them non-independent IPN hydrogels.
This could be accomplished through imbuing covalent cross-links between the
gelatin and gellan gum networks which could be accomplished by creating the
hydrogels with modified (methacrylated) polymer analogues, or perhaps using high
energy radiation based cross-linking approaches. A more thorough study of the
rheological properties of ICE hydrogel microsphere suspensions in hydrogel
solutions would be beneficial to confirm their thixotropic properties. Thixotropic
hydrogel solutions are useful for extrusion printing of hydrogels because they are an
avenue to layer-upon-layer construction of 3D scaffolds.
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